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Bacterial Vaginosis is one of the most common vaginal infection that affect 50% of women 
globally between the ages of 14-49, yet its aetiology remains unknown. Antibiotics or vaginal 
creams are usually prescribed to women to treat the infection however, reoccurrence is 
common after a year of treatment. Therefore, this condition desperately needs a new 
approach to developing an effective treatment. The aim of this thesis was to develop a 
microfluidic platform that can realistically mimic the in vivo vaginal epithelium tissue as an in 
vitro system which can then be used by clinicians and researchers to gain a better 
understanding of bacterial vaginosis (BV). The Vagina-on-chip (VOC) was developed using 
multiple techniques that combined micro-engineering, 3D printing, electrospinning, and cell 
culture to mimic the mechanical, biochemical and physical aspects of vaginal tissue. 
VOC platform comprised of three layers, top and bottom microfluidic channels to provide 
nutrients to the central layer, the membrane held in suspension to support the growth of 
vaginal tissue. The membrane was fabricated using natural and synthetic polymers via 
electrospinning technique. Composite membrane made with gelatine (GE) and 
polycaprolactone (PCL), a mixture of natural and synthetic polymers was found to be the 
optimal membrane for cell culture. This membrane was chosen due to its fibre size (257.25 
±72.92nm) and wettability CA (29.66 °) which provided a large surface area and hydrophilic 
exterior to support growth and cell adhesion of vaginal cells. Mechanical testing revealed that 
composite membrane exhibited similar mechanical properties to vaginal epithelium from 
non-prolapsed women. The composite membrane had a stress failure at 1.6MPa with strain 
failure at 12%. Cell viability assays were also conducted on the membranes to test for 
biocompatibility, which confirmed the composite membrane to be the most appropriate 
membrane for the VOC platform. Scanning electron microscopy was performed to visualise 
cell attachment on all membranes which showed the vaginal cells merging to the fibres of 
PCL/GE, PCL/COL and composite membrane indicating that these as-spun scaffolds promoted 
cellular attachments and spreading. Together with these results, the first VOC platform 
prototype was constructed. Due to its early stages in development, further experimentation 
and optimisation is required to evaluate its performance, to support the growth of vaginal 
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Chapter 1 - Introduction  
Bacterial vaginosis (BV) is the most common vaginal syndrome that affects women of 
reproductive age between 14-49. Approximately 50% of women from the developing world 
and 33% from the developed world are affected by this condition on a global basis. It remains 
a formidable problem in women’s genital health as clinicians and microbiologist are yet to 
fully understand its aetiology. At present, there no effective long-term treatment for BV and 
the need for a new approach to model and manage BV is necessary, to gain a better 
understanding of the condition. A new platform, with the ability to mimic the function of the 
vaginal tissues and sustain the human microbiome will provide researchers and clinicians a 
working platform to develop new and alternative treatments for BV and to improve female 
healthcare.  
1.1 Aim 
The aim of this project is to develop a microfluidic device that can mimic the in-vivo vaginal 
tissue, within an in-vitro system.  
A combination of techniques including 3D printing, electrospinning, and micro engineering 
will be used to make the Vagina-on-a-Chip (VOC). The purpose of the VOC is to have a realistic 
platform that represents the human physiology of the vagina, which can be used to study 
factors that disrupt the vaginal microbiome, understand the interaction between vaginal 
epithelial cells and bacterial strains. The VOC also has the potential to replace animal testing 
and provide as a realistic platform that can be used by researchers and clinicians to find better 
or improved treatment for BV and other pathogens that may affect the homeostasis of the 
vagina.   
1.2  Objectives 
To fulfil the aim of the project the following objectives were considered throughout the 
research: 
1) To develop a 3D microfluidic VOC device. 
2) To develop a biocompatible membrane to support the growth of squamous epithelial 
cells. 
3) To optimise the growth of vaginal epithelial cells 
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4) To evaluate the membranes through mechanical and biological studies 
5) To integrate the membrane into the microfluidic VOC system. 
1.3 Description of Chapters 
This section provides a brief description of what each chapter will be discussing throughout 
the thesis.  
• Chapter 2 Literature review 
This chapter will consist of a thorough literature review on previous systems that have studied 
vaginal tissue in 2D and 3D systems. An overview of current research done on OOC system 
and studies related to female health.  Methods of fabrication for the microfluidic devices and 
cellular scaffolds are reviewed. 
 
• Chapter 3 Design and Microfabrication 
 
This chapter will cover the steps taken to design and create the VOC platform.  
 
• Chapter 4 Electrospinning and membrane fabrication  
 
Chapter 4 describes and explains the process of fabricating the electrospun membrane.  
 
• Chapter 5 Cell work 
Chapter 5 explains the process taken to culture vaginal epithelium cells and validated using 
assays and fluorescence microscopy work. 
 
• Chapter 6 Discussion 
Chapter 6 describes the results from experiments conducted in previous chapters.  
 
• Chapter 7 Conclusion  
The final chapter will conclude the thesis and identify the contribution to knowledge  
• Chapter 8 Future Work 
This chapter will define the potential future work that can be conducted for further research 





1.4 Background  
BV occurs when the natural balance of healthy vaginal microflora with an acidic pH of 3.8-4.5 
is disrupted.  This occurs due to an overgrowth of anaerobic bacteria including Gardnerella 
vaginalis (GV), Atopobium vaginae (AV); and many other anaerobic species and genital 
mycoplasmas which causes the ecosystem of the vagina to alter, resulting in a more neutral 
pH of > 4.5 (Boskey, 2005; Bradshaw and Sobel, 2016). BV is known to be a polymicrobial 
infection that is poorly understood as approximately 400 bacterial species are associated with 
the infection therefore making it difficult for clinicians and researchers to identify the specific 
bacterium that cause BV to occur (Easmon et al., 1992). 
The healthy vaginal microbiota primarily contains Lactobacillus spp. (LB) including L. crispatus, 
L. jensenii and L. iners (Forsum et al.,  2005); these bacteria play a vital role in the hosts 
defence against pathogens by producing antimicrobial molecules, lactic acid and bacteriocins 
which help maintain vaginal pH (Truter and Graz, 2013). Vaginal lactobacilli are regulated by 
hormones circulating through the body which cause the vaginal epithelia cells to produce 
glycogen.  Glycogen has a specific role in inhibiting BV occurrence. Glycogen is metabolised 
by the LB producing lactic acid which is responsible for normal vaginal acidic conditions  
(Turovskiy et al.,  2012). Hydrogen peroxide produced by LB inhibits bacterial overgrowth and 
further inhibits bacteria from attaching to the walls of the vagina.    
About 50% of women who experience BV are asymptomatic (Hoffmann et al., 2014). Those 
who are symptomatic experience abnormal watery, thin or greyish colour discharge.  There is 
a noticeable change in the pH of the vagina when BV is present.  The vaginal pH increases to 
pH > 4.5 and in severe cases develop a fishy smelling odour which mainly occurs during 
menstruation or after having sexual intercourse (Watson, 2019).  
Whilst BV is not a sexually transmitted infection (STI), 1 in 3 women will be affected by this 
condition at some point in their lives as it is associated with sexual behaviour (Truter and Graz, 
2013). Women with BV are susceptible to STIs including Chlamydia trachomastis, Neisseria 
gonorrhoea and human immunodeficiency virus (HIV) (Gillet et al, 2011).  This is due to the 
depletion of the protective Lactobacillus spp.  in the vagina.  GV was identified as the first 
pathogenic species to create a polymicrobial biofilm that strongly attaches to vaginal 
epithelium; this becomes a scaffold for other microorganisms to adhere to (Truter and Graz, 
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2013). This GV biofilm acts as a barrier that prevents the immune system and antibiotics 
penetrating and eliminating underlying bacteria. The biofilm is composed of polysaccharides, 
proteins and nucleic acids, which due to their distinct gene expression and physical structure  
increases in bacterial resistance to many negative stimuli such as vaginal cream and gels, 
immune defence and antibiotics (Patterson et al., 2007). This causes the survival rate of GV 
to increase, even with the presence of LB producing hydrogen peroxide and lactic acid; this 
results in a high risk of BV reoccurrence and other biofilm related infections.  
1.5 Contributing Risks Factors  
The cause of changes to bacteria levels in the vagina are unknown but contributing risks 
factors such as having multiple or changing partners, douching and using scented soaps 
increase the risk of infection. BV is associated with significant health risks that if left untreated 
can lead to reproductive and obstetric issues increasing the consequences of pelvic 
inflammatory disease (PID) which can lead to infertility, premature birth and miscarriages 
(Gillet et al., 2011; Bitew et al., 2017). A recent study by (Nye et al., 2020) examined whether 
women with symptomatic BV were at risk of having recurrence with Mycoplasma genitalium 
(MG).  MG is an emerging STI known to effect women’s health especially in acute or chronic 
conditions such as PID and premature birth, however it is an infection that is usually 
underdiagnosed as the pathogen is difficult to culture and is often asymptomatic. As it is 
associated with non-gonococcal urethritis (NGU) it is possible to detected MG through 
polymerase chain reaction (PCR) to ensure diagnosis. The study showed prevalence of MG 
infection was higher in women with vaginitis caused by BV, however, this was indicated 
independently by Nugent score for MG only and not associated with clinician manifestation 
of BV. If left untreated, BV would present a significant risk of developing symptomatic MG.  It 
was recommended that, better management of BV would be beneficial to decrease the 
likelihood of women transmitting and developing pathogenic infections like MG (Nye et al.,  
2020) which can be difficult to treat and is beginning to show high levels of antimicrobial 
resistance. Patients with MG are usually given common antibiotics like moxifloxacin to treat 
the infection by damaging the cell wall of bacteria, however MG does not have a cell wall and 





1.6 Physiology of the vagina  
The vagina is an organ that is part of the female reproductive system and is involved in a 
multitude of functions due to the response of hormonal changes. These changes are  
experienced throughout a woman’s life span, especially during puberty, menstruation, 
pregnancy and menopause (Gold and Shrimanker, 2019). The vagina plays a vital role during 
childbirth, intercourse, and female sexual arousal. During childbirth and pregnancy, the 
vagina is also known as the birth canal which provides a pathway for the mother to safely 
deliver the baby naturally from the uterus to the outside world.  
During childbirth, the vagina is able to expand and stretch to more than three times its normal 
diameter (Brusie, 2019). During sexual intercourse and sexual arousal, the vagina can increase 
in length and width of up to 10cm in response to pressure. As the walls of the vagina are made 
up of an elastic mucous membrane that is able to stretch and contract with the aid of the 
pelvic muscles to the size of the penis and other objects resulting in sexual pleasure and 
fertilisation. During menstruation, the vagina acts as a passage for menstrual flow and tissue 
to leave the uterus.  
Another function of the vagina is its immune defence to protect the female reproductive 
system against harmful pathogens by maintaining a natural balance of commensal bacteria in 
the vaginal microflora, chemical signalling and maintaining the internal acidic pH environment 
(Gold and Shrimanker, 2019; Taylor, 2020). As described previously, the normal vaginal flora 
contains Lactobacillus spp., which produce a protective barrier by producing lactic acid and 
hydrogen peroxide preventing bacteria from attaching to the inner walls of the vagina. Lactic 
acid helps maintain a low pH in the vagina whereas hydrogen peroxide kills the bacteria; both 
are important in managing the healthy ecosystem in the vagina (NHS England, 2018)  
1.6.1 Anatomy of the vagina 
The vagina is a fibromuscular canal about 8cm in length and 3cm in diameter. The upper 
region of the vagina connects to the cervix (womb) of the uterus leading towards the lower 
region, vulva the opening of the vagina.  The vaginal canal is situated between the urethra 




Figure 1 The anatomy of the vagina, created with BioRender.com 
 
The vaginal wall consists of three layers, the mucosa, muscularis, adventitia.  The mucosa is 
composed of a thin layer of nonkeratinizing stratified squamous epithelium that is situated 
on loose connective tissue know as lamina propria which contains no glands making it flexible 
(J.Paavone, 1983; Siddique, 2003).  However, the mucus that lubricates the vaginal walls is 
due to the Bartholin’s glands located  in the labia, outside the vagina ensuring that the area 
is always moist (NHS England, 2018a).   
The vaginal epithelial cells are found in the mucosa layer in the form of folds called rugae 
which are supported by oestrogen and provides an increased surface area for extension. The 
second layer, the vaginal muscular, contains smooth muscle made from collagen and elastin 
that are present as inner circular and outer longitudinal fibres which offers the capacity of the 
vagina to expand and contract providing support during sexual intercourse and childbirth 
(Siddique, 2003). Lastly, the outer layer called the adventitia is made up of dense fibroelastic 
connective tissue which provides the vagina support from is surrounding structures. The outer 
layer of the adventitia also contains blood and lymphatic vessels, nerves and nerve sensory 
















Figure 1.2 Histology image presenting the layers of the vagina (Sugiritama, 2009). 
1.6.2 Vaginal Microbiota and Acidic Environment  
 
The vagina is a very complex ecosystem which contains approximately 7-9 CFU/ml of 
Lactobacillus spp.  in the vaginal fluid (Aleshkin, Voropaeva and Shenderov, 2006). With 
Lactobacillus being the predominant bacteria species found in vaginal microflora is known to 
the most aciduric bacteria amongst acidophilic lactic acid bacteria making it thrive in an 
environment with a low pH of 4 (Vaneechoutte, 2017). The production of Lactobacillus spp.  
changes over a women’s life, at the beginning, a young premenarchal girl’s vaginal microbiota 
is more neutral/alkaline, but as oestrogen  levels increases with ovary function the microbiota 
changes causing the pH to decrease (Devillard et al.,  2004). As the vaginal epithelium thickens 
the level of glycogen builds within the tissue. The Lactobacillus spp.  metabolise the glycogen 
and as this breaks down it increases the production of lactic acid resulting in a low pH 
environment of between 3.8-4.5 (Devillard et al.,  2004).  The low pH ecosystem  helps 
maintain the natural microflora, protect and prevent disease causing microorganisms to enter 
the vagina, kill sperm and produce immunological protection against bacterial growth (Gold 
and Shrimanker, 2019).  With the combination of lactic acid and hydrogen peroxide the vagina 
is also known to be a self-cleansing organ, however contributing risk factors such douching or 
washing out the vagina with scented soaps can disrupt the natural balance of microflora 
causing irritation and an increased risk of infection and syndromes including bacterial 
vaginosis to occur . (Gordon Betts et al., 2013).  
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1.7 Diagnostic Measurements   
In women, the normal healthy vaginal environment consists of having a white discharge, high 
in viscosity, with a pH of 3.5-4 and presence no odour but these conditions change when the 
vaginal ecosystem is disrupted by anaerobic bacteria causing syndromes like BV to occur. To 
diagnose BV, clinicians use two standard methods known as the Amsel’s diagnostic criteria 
and the Nugent scoring system.  Amsel’s criteria consists of 4 markers (Eriksson, 2011) seen 
in Table 1.1. If 3 out of 4 markers are consistent with the presence of BV, then this indicates 
a positive diagnosis. 
 




Amsel Criteria for the Diagnosis of BV 
1 
Presence of vaginal discharge – if thin, white/grey discharge coats the 
vaginal walls. 
2 pH of vaginal secretion – if pH of vaginal discharge is >4.5. 
3 
Whiff test – if by adding 10% of potassium hydroxide solution (KOH) to 
vaginal discharge produces a fishy smell is which is the usual outcome 
from vaginal specimen from women with BV. 
4 
Microscopic examination of vaginal epithelia cells – if >20% of vaginal 
epithelia cells are surrounded by anaerobic bacteria called clue cells. 
 
 
Figure 1.3 Vaginal epithelial cells: (A) Normal vaginal epithelial cells surrounded by the microflora Lactobacillus, 
rod like shaped bacteria; (B) Vaginal epithelial cells surrounded by bacteria Gardnerella vaginalis forming clue 
cells is normally found in vaginal samples obtained from women with BV  (Todar, 2008). 
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The Nugent score is a Gram stain scoring system that is used to assess the alteration in the 
vaginal flora (Sha et al., 2005). Vaginal swabs are used to collect samples to create vaginal 
smears which are then fixated on microscopic slides and stained for analyses. The Nugent 
score is calculated by evaluating the presence of bacteria morphotypes which are the 
classified into 3 categories: gram-positive rods, gram-negative coccobacilli form and curved 
gram-negative rods. Scores of 0-3 is considered normal (Lactobacillus Spp.), scores of 4-6 
represent a mixture of bacteria and scores of 7-10 indicates the presences of BV (reduction 
of Lactobacillus Spp.) with an increase in other pathogenic bacteria (Martin and Marrazzo, 
2016).  
1.7.1 Treatment of BV 
Women are usually prescribed first line medication which include the choice of antibiotics 
metronidazole taken orally for 5-7 days or to apply clindamycin vaginal cream/ gel  with a cure 
rate of 60-70% (Thulkar et al,. 2010). 50% of women experience reoccurrence within 6-12 
months of treatment (Bradshaw and Brotman, 2015b).  Studies have been conducted using 
alternative therapies using probiotics and prebiotics combined with antibiotics were 
recommended to women with BV to revitalise the native microflora.  Although these 
treatments are promising and have been shown to improve the cure rate of BV in patients, 
further analysis is required. This is  due to the limited evidence showing probiotics provide 
any real benefit or impact for women with BV (Senok et al.,  2009; Huang, et al., 2014; Wang, 
et al., 2019; van de Wijgert et al., 2020).  Senok et al.,  2009 and Bradshaw and Brotman, 2015 
both expressed the need for a standardised protocol to analyse and evaluate alternative 
therapies; the effect that probiotics have on patients with BV must be conducted in well-
designed randomised clinical trials with a larger patient population for prolonged treatment 
of 6-12 months.  
1.8 Limitations of current models  
Several studies have attempted to use nonhuman primates animal models which include the  
pig tailed macaque, chimpanzees and murine to research and advance our understanding of 
BV pathogenesis factors that affect the vaginal microbiota, the role of the biofilm, 
transmission mechanisms and enhancement of other infection  (Herbst-Kralovetz et al.,  
2016). However, these models impede the opportunity to gain a better understanding of the 
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condition as they do not truly mimic the human vaginal environment. The vaginal 
environment of these animal models usually have a pH > 5 and differ in the content of vaginal 
microbiota in comparison to the microflora found in the human vagina (Bradshaw and 
Brotman, 2015; Herbst-Kralovetz et al., 2016; Martin and Marrazzo, 2016). A study conducted 
by Johnson et al., 1984  initiated G. vaginalis vaginal colonization in pig tailed macaques and 
chimpanzee models, but these models failed to express clue cells or detect any changes in pH 
(Johnson et al., 1984). Noticeably it can be difficult to establish the human microbiome in an 
animal model due to their native microbiome being highly resilient. This will be discussed in 
greater depth in Chapter 2. 
1.8.1 Organ - on -chip  
With animal models being expensive and failing to predict human response to new 
medication as they are unable to mimic human pathophysiology, there is a need to find 
alternative ways to model human diseases in vitro to develop new treatment and 
personalised medication ( Ingber, 2017). New studies are now being focused on the latest 
technology, Organ-on-Chip (OOC), where organs of interest are being created using 
multidisciplinary research and techniques including 3D printing, microengineering and tissue 
engineering to use small scale tissues to mimic organ like functions. The OOC is designed to 
provide researchers a potential platform that could replace animal testing and provide a 
realistic model to capture and monitor the initiation, progression and treatment of a specific 











Chapter 2- Literature Review  
 
In this section, a thorough literature review has been conducted on three distinctive areas 
that are required in order to create an organ on a chip device: cellular/tissue culture, scaffold 
fabrication and microfluidics. By identifying the knowledge currently available in the 
literature, the information will then be combined to design and create the VOC.   
2.1 2D modelling of Vaginal Tissue 
The vagina is a complicated ecosystem, however not much is known about the vagina, 
especially the regulation of microbiological flora. A study done by (Fichorova et al., 2011) 
observed the novel vaginal microflora colonisation model which provided a new insight into 
microbicide mechanism of action. To understand how the vaginal microflora regulated the 
epithelial and bacterial components in order to maintain homeostasis. Human immortalised 
endocervical (End1/E6E7), ectocervical (Ect1 /E6E7) and vaginal (Vk2/E6E7) cell lines were 
cultured to compare the physical properties of the monolayers of vaginal tissue to 3D cell 
culture of VEC-100 tissues, derived from primary human ectocervical epithelial cells. These 
cells used a permeable membrane to support the 3D culture which resembled the bactericidal 
and immune properties of normal tissue origin. Both cultures were used to study the effects 
of bacteria found in women with BV including (L. acidophilus and L. crispatus). 
The aim of this study was to improve the preclinical and phase I safety of women acquiring 
human immunodeficiency virus (HIV) during phase II and III clinical trials of microbicides. The 
cultures were exposed to cellulose sulphate (CS) and hydroxyethylcellulose (HEC) to 
understand how both the vaginal epithelium and microbiome interact with these drugs and 
why pre-clinical models failed. Overall, the results showed interaction between the drug, 
epithelium and microflora.  The work showed evidence that the microbiome of the vagina 
regulates the immunity of the epithelial layer (Fichorova et al., 2011).  
Another study by Devillard et al. examined a novel approach to understanding the vaginal 
microflora but this time in postmenopausal women under hormone replacement therapy. 
Devillard et al. investigated the use of new molecular technologies to identify vaginal bacterial 
species. 19 postmenopausal women were provided with oestrogen therapy, and vaginal flora 
was observed over a period of three months and analysed using polymerase chain reaction 
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(PCR), DNA sequencing and gel electrophoresis. Oestrogen plays a vital role in menopausal 
women as it stimulates proliferation of vaginal epithelial cells and produces high levels of 
glycogen.  As discussed in Chapter 1, increased glycogen is broken down by Lactobacillus Spp. 
in the vagina to help maintain pH (Boskey ER et al., 1999).  Following menopause, women are 
more likely to  sustain infections that affect the lower genital tract due to a reduction of  
oestrogen  secretion; this further causes the depletion of Lactobacillus Spp. which and 
therefore microorganisms associated with BV and urinary tract infections (UTIs) can colonise 
(Ginkel et al., 1993).  
 
Medications such as vaginal estriol cream has shown a great impact on restoring the 
Lactobacillus Spp. bacteria and reduce the rate of (UTIs) (Ginkel et al., 1993). Due to the 
complex anaerobic conditions and nutrients required to grow vaginal microorganisms many 
microbiological techniques have been used to recover the bacteria, but this has been difficult. 
However, using PCR and gel electrophoresis has made it possible to identify bacterial 
composition of the vagina in pre- and post-menopausal women (Burton and Reid, 2002; 
Burton, Cadieux and Reid, 2003).   
 
Devillard et al. 2004 conducted a study to investigate the  vaginal microflora in 
postmenopausal women under hormone replacement therapy to determine the effect of oral 
intake of hormone replace therapy (HRT) and premarin-conjugated equine oestrogen on the 
vaginal flora (Devillard et al., 2004).  The 19 women who took part in the study did not have 
a sign of UTI or any other vaginal infections. The women given HRT were observed and swab 
samples were obtained every 30 days over a period of 3 months. DNA was extracted from the 
bacteria present on the vaginal swabs and bacterial species were identified following PCR, gel 
electrophoresis and DNA sequencing analysis. The vaginal flora of all subjects contained 
Lactobacillus Spp., 44% of the samples contained other species such as Gardnerella vaginalis 
and Escherichia coli at a low percentage rate. The two main Lactobacillus Spp. bacteria found 
in the samples were L. iners and L. crispatus. This study indicates that the HRT has shown to 
maintain a stable environment of vaginal microflora by restoring Lactobacillus Spp. to ensure 
a healthy vagina for menopausal women, as well as reducing the risk of urogenital infection 





Bradshaw and Brotmans’ review on ‘Making inroads into improving treatment of bacterial 
vaginosis – striving for long term cure’ expresses the fact that BV is a common vaginal 
infection that affect women on a global basis and is understood to be an enigma in women’s 
health due to its unknown aetiology. BV is known to affect women during pregnancy i.e., low 
birth weight and miscarriages. Though BV is not classed as a sexually transmitted infection 
(STI), it is associated with STIs due to it high prevalence rate. This review also discusses the 
function of Lactobacillus Spp. microbiota and other bacterial species found in the vagina and 
how clinicians are determined to find a long-term cure for this condition to improve women’s 
health. The aetiology and pathology of BV is not yet fully understood however, the depletion 
of Lactobacillus Spp. microbiota increase the prevalence of BV to occur. “Most vaginal 
Lactobacillus Spp. provide broad-spectrum protection against pathogens through production 
of potent antimicrobial molecules, bacteriocins and lactic acid” (Aroutcheva et al., 2001; 
Boskey et al., 2001; Donia et al., 2014).  
 
It is still unknown what causes the recurrence of BV whether, due to the current antibiotics 
or other external factors like douching or being reinfected through STI (Ness et al., 2002). 
Figure 2.1 presents the potential strategies that can be used to reduce the likelihood of BV 
recurring. It also depicts what causes BV to reoccur, for example, women who are affected by 
BV are prone to being infected with an STI, especially those who have multiple sexual partners 
over a lifetime (Fethers et al., 2008). Overall, the article concludes that there have been no 
advances for new treatments to improve the cure rate for BV. Recent studies have only just 
started to understand the environment of the vagina and the importance of vaginal 
microbiome and how the changes within its composition can affect women’s health 









Figure 2.1. Causes of recurrent of BV and potential strategies to reduce its prevalence (Bradshaw and Brotman, 
2015a) . 
Bradshaw and Brotman clearly state that clinicians and researchers are making the need for 
a new system that would be able to manage BV, find better treatment and develop effective 
prevention strategies to reduce the recurrence of any BV associated conditions as a priority 
(Bradshaw and Brotman, 2015a).  
A study by Gilbert et al. (2013) observed the clinical features of BV in a murine model of 
vaginal infection with GV. BV, a dysbiosis of vaginal flora is characterised by the shift in 
balance of dominating Lactobacillus Spp. replaced by a polymicrobial mixture of anaerobic 
bacteria and Gram-negative bacilli (Gilbert et al., 2013). Women with BV are prone to STIs 
and can experience adverse effects during pregnancy such as premature birth. Furthermore, 
several bacterial species are associated with BV the causes of the condition through 
biochemical, cellular and clinical features remain elusive.  GV, the most frequent bacterial 
species isolated from BV patients is also known to be the first bacterium implicated in the 
pathogenesis of BV which causes cytolytic toxin production and the formation of biofilm 
(Gilbert et al., 2013). The most important diagnostic feature of BV through culutre is the 
presence of clue cells, this is when bacteria assoicated with BV  such as GV coat or interact 
with the vaginal epithelial cells.   
Vaginal samples from women with BV have indicated bacteria adhering to the surface of the 
cells. In order to understand whehther G. vaginalis plays a vital role in initiating clue cells, a 
murine model, displaying BV characteristics was used to examine the  GV vaginal infection. 
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The murine vaginal infection model demonstrated that GV was adequate in causing BV 
phenotypes suggesting that this particular bacterial species contributes to the aetiology of 
BV. The study compared clinical specimens from women with BV against the murine model 
which revealed vaginal epithelial cell exfoliation and bacterial adherence to the vaginal 
epithelial cells in comparison to specimens with normal flora. It was also noted that the 
murine model expressed similar phenotypic features parallel to human BV making the system 
an ideal experiment tool that has the potential to gain a better understanding of the role GV 
plays in the vagina ( Gilbert et al., 2013).  
In the study done by (Rosa R. Yu, et al., 2009) the vaginal Lactobacillus Spp. colonisation and 
live microbial environment was investigated using a Chinese rhesus macaque (Macaca 
mulatta) model. The study was conducted to establish a model that would closely relate to 
human physiology and sensitive to mucosal HIV infection. Due to the depletion of vaginal 
lactobacilli, the vagina is prone to bacterial infections and increases the risk of acquiring other 
conditions such as HIV and herpes simplex virus type 2 (HSV-2). Amongst the animal models 
used which include rats, mice, dogs, hamsters and guinea pigs it has been reported that these 
models contain a low number of vaginal lactobacilli compared to the vaginal flora found in 
women at the reproductive age, and therefore are not suitable for such studies regarding the 
microbial environment of the vagina.  
Though these animal models have been used in previous studies, they unfortunately do not 
accurately mimic the human female lower reproductive tract as they have an oestrous cycle, 
as well as reproductive physiology and anatomy differ from that of humans  (Pot et al., 1993; 
Patton et al., 1996; Noguchi K, Tsukumi K, 2003; Poonia et al., 2006). The aim of the study was 
to select an animal model that expresses similar characteristics to human physiology, the 
Chinese rhesus macaque was selected as its reproductive system shares many similarities to 
the human reproductive system. The model was developed to test colonisation, efficacy and 
the safety of a new biological approach, that would use a ‘live’ recombinant human vaginal 
Lactobacillus Spp.   to  test  topical microbicides against mucosal transmission of pathogen in 
the vagina (Rosa R. Yu et al., 2009).    
To develop the macaque model for examining Lactobacillus Spp. based microbicides, 
microflora samples were obtained from both the vagina and rectum of 13 female Chinese 
rhesus macaques and analysed with cultivated bacteria recognised by 16S rRNA gene 
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sequencing. It was reported that 12 out of 13 macaque models maintained a large number of 
lactobacilli colonies with Lactobacillus johnsonii being the predominant species. Lactobacillus 
Spp. derived from the vagina and rectum of the same model presented different genetic and 
biochemical profiles indicating that microflora from the rectum may not be a reservoir for 
harbouring endogenous vaginal Lactobacillus Spp.. Vaginal flora found in healthy women of 
child bearing age is normally dominated by Lactobacillus acidophilus complex which contains 
six distinct species: L. acidophilus, L. crispatus, L. gasseri, L. gallinarum, L. amylovorous, and 
L. johnsonii. (Johnson et al., 1980; Lauer, Helming and Kandler, 1980; Fujisawa et al., 1992; 
Zhou et al., 2004). 
Through molecular techniques, L. gasseri, L. jensenii, L. crispatus, and L. iners have been 
indicated to be the dominating Lactobacillus Spp. found in the human vagina of reproductive 
women. The interesting discovery of finding L. acidophilus complex in the vagina of macaque 
models suggested that the microenvironment is similar to that of the human vagina and 
therefore having the ability to maintain the growth of vaginal lactobacilli. Due to the 
similarities between the rhesus macaque and human vaginal microflora this animal model has 
shown good potential in offering support for pre-clinical evaluation of safety and efficacy of 
the Lactobacillus Spp. based microbicides. Animal testing is however costly, has ethical 
problems, and can never fully replicate the human vagina and associated microbiome.  
2.1.1. 2D vs 3D cell culture  
Two dimensional (2D) cell culture is the most common in vitro technique used to biological 
experiments and often used to improve our understanding of cell interactions, tissue 
morphology, mechanism of diseases and response to drug treatment (Kapałczyńska et al., 
2018). In 2D adherent cell culture, cells are normally grown in plastic culture flasks or petri 
dishes where cells cultivate as monolayers and adhere to the surface Figure. 2.2. Researchers 
generally use this technique due to its simplicity, cost effectiveness and ease of observation 
for results analysis. Many studies have been done on 2D cell culture making it easier to 
compare results from previous literature (Khoruzhenko, 2011). However, there are limitations 
to 2D cell culture as this method does not truly represent how cells grow and function in the 
human body. Cells in the human body experience mechanical forces of stress, strain, shear, 
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gravity, tension and compression on a daily basis which, cells grown in 2D are not exposed 
too.  
2D cell culture is normally used to test new drugs in the pharmaceutical industry, but due to 
lack of predictivity can lead to an increase failure during clinical trials and cost for the 
development of new drugs (Khoruzhenko, 2011). Though 2D cell culture is a simple and easy 
process where cells are grown within a controlled environment, cells must be well maintained 
to avoid contamination. Cells are fed growth media which contain vital nutrients for cells to 
grow, but as the media is consumed by the cells, cells also release waste products making the 
environment toxic causing cell death and reduction of nutrients  
3D cell culture is a method that is not as commonly used as 2D cell culture but is a technique 
that better represents human tissue in vitro. Growing cells in 3D has the ability to exhibit how 
cells behave in response to diseases and treatment. These biomimetic tissue models provide 
an accurate representation of in vivo scenario in this case physiology, structural complexity, 
cell to cell interactions and establishing a homeostatic environment for a specific length of 
time . 3D models are sometimes linked with microfluidics which increases the complexity of 
this system. The integration of flow is crucial for all functioning tissue which enables cells to 
communicate through differentiation and metabolic adaptation. Microfluidics allows for the 









Figure 2.2. Comparison between 2D cell culture and 3D cell culture highlighting the key difference when growing 





With such models being available, they have the potential to replace animal testing and 
provide a realistic solution to understanding diseases and responses to new drugs and 
treatment in an efficient way. However, 3D cell culture models can be expensive, time 
consuming and complex in nature making it difficult to analyse results. For example, 
microscopic analysis can become difficult due to their large scale. Needless to say, this 
method has potential in biomedical research to offer a greater understanding of cell culture 
in a profound and realistic way.   
2.2 3D modelling of Vaginal tissue 
The vaginal epithelium is characterised by sheets of stratified squamous epithelial that 
express tissue-specific proteins, produce mucus glycoproteins and support enzymatic and 
pathological defence. The cells also exhibit morphological structures which include, cell to cell 
adhesion features, microfolds and micro-ridges (Fichorova, Rheinwald and Anderson, 1997; 
Hjelm et al., 2010). The cells play a vital role in the immunological response to pathogens 
through toll-like receptors (TLR) which produces cytokines, chemokines and signalling 
pathways (Fichorova and Anderson, 1999; Quayle, 2002; Herbst-Kralovetz et al., 2008). It is 
these physiological attributes of the vaginal epithelial cells that are required to develop a 3D 
model which can be used to study syndromes and infections that affect the vagina along with 
further treatment. 
A study done by Hjelm, et al., (2010) developed an in vitro 3D organotypic human vaginal 
epithelial cell model using the rotating wall vessel (RWV) bioreactor technology which 
managed to capture the in vivo environment, structural and functional properties of vaginal 
epithelial cells which exhibited stratified squamous epithelia with microvilli, microfolds and 
tight junctions. The 3D model was used as a platform to carry out toxicity tests of microbicides 
targeting STI infections, replacing existing system such as  surgical explants and animal models 
(Hjelm et al., 2010).  
To develop the organotypic human vaginal epithelial cell model the human vaginal cells were 
grown on porous collagen coated microbeads cultivated in the RWV bioreactor rotating under 
a low fluid shear conditions which created 3D vaginal epithelial cell aggregates.  The 
experiment was carried out in 2 stages, early and late development.  After 1-21 days in the 
rotating culture scanning electron microscopy (SEM) presented monolayer of vaginal cells on 
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the microbeads during early development as shown in Figure 2.3. Cells at this time point 
varied in size and presented convex apical cell shape with light microvilli structures. 
After 39-42 days cells SEM and transmission electron microscopy (TEM) were used to confirm 
surface morphology presenting differentiation and polarisation of 3D vaginal epithelial cell 
aggregates during late development. The aggregates were densely packed with microvilli at 
different lengths, vaginal microfolds knows as rugae and micro-ridges as well as secretory 
vesicles of mucus/deposits between adjacent cells on the apical cell surface which can been 
seen in Figure 2.4 (Hjelm et al., 2010). With this model being able to produce 3D cell culture 
expressing in vivo like structures it was considered that it would be used as a potential 














Figure 2.3. SEM presenting the 3D organotypic vagina epithelial cell model, (A) presents single layer of vaginal 
cells after 19-21 days during early development a low magnification;(B) Low magnification SEM of multiple 
flatten vaginal cell layers after 39-42 days during late development (C); high magnification of boxed area in (A) 

































Figure 2.4. Presents the physiological structures of vaginal cells from the 3D model A) SEM of secretory vesicles 
(B) TEM of microfolds (rugae) indicated by the arrows and C) TEM of long microvilli on adjacent walls. Scale bar 
(A) 20 µm (B & C) 2 µm (Hjelm et al., 2010). 
Another study by Łaniewsk et al. (2017) developed a human 3D endometrial epithelial cell 
model to study host interations with vaginal  bacteria and Neisseria gonorrhoeae (Laniewski 
et al., 2017). This model was created again using the RWV bioreactor technology (Radtke and 
Herbst-Kralovetz, 2012) with the previously established endometrial epithelial cell line HEC-
1A. This cell line was isolated from a patient in 1968 with stage 1A endometrial cancer 
(Kuramoto, Tamura and Notake, 1972). Cells were first cultured as monolayers in flasks before 
being transferred to the RWV bioreactor which contained porous collagen coated 
microcarrier beads. Cells were rotated under a low fluid shear microgravity enviroment which 
maintains the cells in free fall. The allows the cells to attach to the microbeads which act as a 
scaffold for them to form 3D aggregates ( Figure 2.5).   
The endometrial epithelial cell (EEC) model demonstrated complex structures and functions 



















Figure 2.5. Presents SEM of structural characteristics of endometrial epithelial cell aggregates on the EEC model 
after 21 days at magnification of x250, x1200 and x4000 respectively. (A) Microbeads covered in single layer of 
endometrial epithelial cells; (B) The white arrows indicates cells proliferation at different stages and the 
microvilli present on the cell surface; (C) The while arrows highlighting the microvilli and secretory/mucus 
material visible on the surface of the cells (Laniewski et al., 2017).  
The EEC model was exposed to native and pathogenic bacteria to conduct infection studies. 
Three bacterial species  were derived from the vagina, cervix and the uterus; L. crispatus the 
common bacterial species found in the microflora of the vagina, Figure 2.6. GV a predominant 
bacterium associated with BV and Neisseria gonorrhoeae a bacterial species responsible for 
sexually trasmitted gonnorrhoea (Laniewski et al., 2017). The EEC model is known to be one 
of the first reported bioreactor models using this particular cell line to study host interactions 
with human EEC. From the infection studies the results demonstrated all that vaginal bacterial 
species and N. gonorrhoeae  had formed colonies on the EEC aggregates. Gonococci was 
reported to produce dramatic changes in morphology to the cortex of the epithelial cells. 
The EEC model is one of the first 3D bioreactor models to use this particular cell line to study 
host interactions with human EEC and to present bacterial colonies interacting with 3D cells 
at their crevice and folds; which can not be  caputured using traditional 2D cell culture. 
Overall, from the experiments conducted in this study it was concluded that the EEC is a 
robust working 3D model that has the potential to be used as a research tool  to challenge 
the system with microbials to achieve a better understanding of the host immune response 














Figure 2.6. SEM of vaginal bacterial species and N. gonorrhoeae effectively colonising in the 3D endometrical 
epithelial cell model. The EEC model was infected for 24 hours with (A) L. crispatus VPI-3199; (B) G. vaginalis 
JCP8066 and (C) N. gonorrhoeae MS11 which showed the characteristic morphologies of each bacterium 
attaching to the surface of the EEC aggregates. Photoshop CS51, Adobe was used to colour the bacteria (A) L. 
crispatus in purple; (B) G. vaginalis in green and  (C) N. gonorrhoeae in blue (Laniewski et al., 2017).  
RWV bioreactor technology is a useful method  that captures the in vivo  structural  and 
functional properties of cells of interest by maintaining cell suspesnion through slow rotation.  
The model provides cell aggregates in 3D, closely resembling native tissue but experience 
minimal mechanical forces.  Therefore, it  does not truly represent or replicate how cells 
normally grow in the human body and the mechanical forces they experience on a daily basis. 
In order to improve this method, mechanical forces must be considered  to mimic the in vivo 
conditions. An alternative method organ-on-chip has taken this into consideration, it has the 
ability to mimic the function of an organ of interest with the mechanical forces being applied 
to replicate the corresponding environment.  
2.2.1 Organ-on-a-chip 
Organ-on-a- chip (OOC) is a new microfluidic method that is evolving in the biomedical 
engineering field. It is an alternative method to understanding human disease in vitro, helping 
to reduce the use of animal testing. OOCs are bioinspired microdevices that can mimic the 
whole human organ function and potentially replace animal testing. These devices can be 
used by researchers to model diseases and develop new drugs to improve healthcare at a low 
cost. An OOC is multichannel 3D microfluidic cell culture chip that has been designed to 
recreate the functional unit of an organ or organs to mimic the biochemical, mechanical and 




Donald Ingber’s group at the Wyss Institute research, Harvard university have created various 
OOCs that include the lungs, kidneys, skin and bone marrow as seen in Figure 2.7. The group 
has developed an automated instrument that links to multiple OOCs via common microfluidic 
channels. The device has been designed to mimic the human body, control fluidic flow and 
cell feasibility allowing for real time observation of cell culture and interconnected 
biochemical, biomechanical and physiological properties. This new system is called the body-
on-a-chip which has the ability to respond to new drug development providing a platform for 
testing as well as ensuring the efficacy and safety of the drugs (Human Organs-on-Chips, 
2017). 
To create the human-on-a-chip, each device was fabricated using a clear flexible polymer that 
contained hollow microfluidic channels lined with living human cells depending on the organ 
on interest; this was interfaced with human endothelial cells to create an artificial vascular 
system. In order to mimic similar physical microenvironment that cells experience under 
normal circumstances, mechanical forces were applied to the system establish breathing 
motion for the lungs and peristalsis like deformation for the intestine.  
Figure 2.7. Schematic drawing of Human-on-a-chip and how each chip is interconnected. Each chip has been 
designed to mimic the organ level functions ( Ingber, 2017). 
A study by Huh et al. in 2013 observed the evolution of OOCs. This describes OOCs as micro 
engineered biomimetic systems that provide a platform for the mimicry of a living organs 
combined with microfluidic channels to replicate a functional unit. These microdevices can be 
used to test new drugs and create realistic in vitro models to study various diseases. Huh 
created the lung-on-a-chip device where microfabrication techniques were used to develop 




The design was inspired to capture the mechanism  of breathing in the human lungs  by 
producing  alveolar air sacs, which induces filling of the lungs with air and stretching of the 
alveolar epithelium and then compared to the  vascular endothelium in the surrounding 
capillaries  (Huh et al., 2013a). Two parallel elastomeric microchannel layers were fabricated 
with dimensions of 400 µm wide x 100 µm high and separated by a thin (10µm) flexible porous 
membrane made from Polydimethylsiloxane (PDMS) (Huh et al., 2010). Huh et al. chose these 
specific dimensions for the channels to resemble the average diameter of an alveolus in the 
human lungs. The membrane was then coated with extracellular matrix (ECM) collagen or 
fibronectin to support the growth of human alveolar epithelial cells on the upper channel and 
pulmonary microvascular endothelial cells on the lower channel for 5 days to form 
monolayers on either side of the membrane.   
During the cell culturing process, the channels provided nutrient flow to the cells and 
metabolic waste was removed. Once cells had reached confluence, media was removed from 
the upper channel to form an air-liquid interface on the surface of the alveolar epithelium 
which stimulates cell differentiation and express tissue specific functions. During this stage 
media continued to flow in the lower channel mimicking the dynamic flow in the pulmonary 
capillary blood vessels which provided oxygen and nutrients to the epithelial layer via the 
endothelium. 
To create the breathing functionality on the chip to mimic the mechanically active alveolar-
capillary interface of the human lungs, hollow vacuum chambers surrounded either side of 
the of the membrane and vacuum pumps were used to stretched and relax the PDMS 
membrane containing both the epithelial and endothelial monolayers (Figure 2.8). This 
produced a cyclic suction which replicated the rhythmic breathing momentum similarly 
observed in the air sacs of living human lungs  (Huh et al., 2013a).  
Fabricating the microdevice took around 3.5 days. The device was able to reproduce complex 
organ level including the responses to bacteria and inflammatory cytokines in the alveolar 
spaces which cannot be monitored in conventional in vitro cultures. With this approach Huh 
et al. 2013 further developed a nanotoxicology model to evaluate the effects of breathing 
nanoparticle toxicities and extra pulmonary absorption which was not possible using static 
cultures. Furthermore, OOC microdevices have shown their capability in providing an 
alternative solution to conventional  cell culture models,  replacing animal models and 
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reducing the cost of clinical trials for screening of newly developed drugs and toxicology 










Figure 2.8.  (A) multi-layered lung-on-a-chip microfluidic device (B) two cell cultured layers separated by a porous 
PDMS membrane. Vacuum chamber on either side allows the membrane to be stretched (Huh et al., 2013) 
The Gut-on-a-Chip was developed using the same approach by Bein et al. 2018 to investigate 
the human intestinal physiology and pathophysiology. The human intestines are responsible 
for many functions in the gut which includes digestion, secretion, absorption and motility. 
The intestine provides a protective epithelial layer between the digestive environment and 
the rest of the body. The intestine is known to regulate systematic physiology by metabolising 
drugs and communicate with other organs like the liver and pancreas through a portal flow.  
The intestinal microflora plays an important role in maintaining the homeostasis of intestinal 
health and immune modulation. Analysis of gut microbiome interacting with human intestinal 
cells have been limited due to the difficulty in co-culturing microbes found in gut with 
intestine epithelial cells for more than 1 day through conventional cultural models or 
organoid models.  
The gut-on-chip was fabricated in a similar way to the lung-on-chip. The microdevice 
contained 2 hollow microfluidic channels with dimensions of less than 1mm wide in order to 
support laminar flow of nutrients to cells during culturing process. The channels were again 
separated by a porous membrane made from PDMS at thickness of <20µm (Figure 2.9). The 
membrane was coated with ECM to support the growth of the intestinal epithelium on the 
upper channel and capillary endothelium on the lower channel to re-create the intestinal 
tissue-tissue interface. The membrane is surrounded by 2 hollow channels on either side to 
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which vacuum cyclic suction is applied in order to stretch and relax the membrane with 
adherent intestinal epithelial cells. This was done to replicate the mechanical forces cells 
experience during peristalsis (Bein et al., 2018).  
Under these conditions the human Caco-2 intestinal epithelial cells were able to form villus 
and produce mucus inside the dynamic platform. With the continuous flow of nutrients 
provided to the cells and the formation of villi and mucus, the platform provided the 
opportunity for co-culturing cells will commensal microbes for example Lactobacillus 
rhamnosus which was applied into direct contact with the epithelial cells through the  upper 
channel for 5 days (Bein et al., 2018). 
The interaction of Lactobacillus rhamnosus did not compromise the integrity of the barrier of 
the intestinal cells. From this the gut-on-chip showed that it was possible to co-culture cells 








Figure 2.9. A multi-layered Gut-on-chip microfluidic device constructed with two cell cultured layers separated 
by a porous PDMS membrane lined with human villus intestinal epithelium and human vascular endothelium 
under fluid flow and peristalsis like strain forces on either side of the membrane. (Bein et al., 2018). 
The chip was used to understand the complex immune microbiome inflammatory interactions 
and chronic inflammatory diseases e.g., inflammatory bowel disease (IBD). With the ability to 
express organ like functions, the gut-on-chip provides researchers with a new insight to 
understanding the biological, chemical and mechanical properties within the intestinal 
microenvironment its structure, function and physiology of living human intestines. The 
model also offers a  new approach into developing personalised medication (Bein et al., 2018). 
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2.2.2 Female reproductive OOC systems  
 
Many OOC devices have been developed as discussed previously, there is some research into 
the female reproductive system. Recent studies done by Woodruff’s group focus on 
understanding women’s health with more knowledge by studying the female reproductive 
system in further detail including blood clots and production of hormones that affect the body 
to sexual health (Woodruff, 2013b). 
Limited knowledge can be derived from examining conventional cell culture and animal 
models. This encourages the need for a new model that can be used to analyse how the 
reproductive system works and eventually be used as a testing platform for the development 
of new drugs for better treatment to improve female healthcare. 
A 3D model of female reproductive system is under development by Woodruff’s group.  The 
systems goal is to amalgamate the reproductive organs into a network system to form a chip 
called FemKUBE, Figure 2.10. The device contains the main reproductive tissue that make up 
the female reproductive system, “ovarian follicles,  fallopian tube, uterus, endocervix, 
and ectocervix” (Woodruff, 2013b) 
The group has established 3D cell culture using the steroid hormones oestrogen and 
progesterone, this allowed the device to mimic menstrual cycle which no in vitro assessment 
has ever accomplished. A new microfluidic device has also been created for ovarian follicles 
which in vitro creates the menstrual cycle over 28 days. Both these platforms will lead to 














Figure 2.10. Draper microfluidic platform FemKUBE. The bottom layer consists of air channels which controls the 
flow of media through the middle layer. The media is transported to the top layer where chamber house cell 
culture or with fresh media and used media for experimental analysis (Woodruff, 2013b). 
Woodruff has also recently developed the EVATAR which is a small device that depicts the 
female reproductive tract and the liver on an interconnected microfluidic chip. The platform 
contains 3D models which sustain five different tissues working together which include the 
ovaries, fallopian tube, uterus, cervix, vagina and the liver. A specifically formulated fluid 
which acts as blood is pumped through the system to the organs allowing each tissue to 
communicate with one another via secreted substances such as hormones. With this 
functionality the platform is able to resemble how different organ tissue would  normally 
work together in the human body (Woodruff, 2013a). 
The EVATAR was designed to study endometriosis, fibroids and cancers that affect the female 
reproductive system as well as be used to evaluate and test the development of new drugs. 
Woodruff states that previous studies were inhibited as each organ required its own specific 
media, therefore a universal media was developed; the media has similar properties to blood.  
Applying this blood like media to the platform allowed tissues to communicate through the 
media. To conclude with the development of such a platform that closely represents the 
female reproductive system the EVATAR provides researchers the opportunity to study and 
gain a better understanding of the basic hormonal and cellular function in the reproductive 
tract. Furthermore, the platform will be used to understand various types of cancers, STIs and 
benign tumours that affected the female reproductive system.  
The addition of a liver-on-a-chip within the platform allows the device to monitor how drugs 
affect women in response to hormonal levels. The main goal for the EVATAR is to eventually 
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be combined with the human on a chip platform to make one integrated system that can then 
be used to evaluate the effects of drugs on the modelled human body before preforming 
clinical trials with human participants (Figure 2.11)(NIH, 2017).  
As seen in Figure 2.11 the EVATAR platform is as open compartmentalised device designed 
for different tissues of the reproductive system to communicate with each other in order to 
understand hormonal changes and cellular functions. Building on their research, the VOC 
platform will be designed to mimic the function of the vagina in an enclosed microfluidic chip. 
Microflora of the vagina will be introduced to the VOC platform to establish the vaginal 
microbiome environment. The purpose of the VOC is to achieve a realistic model of the 
human vaginal ecosystem to study interactions between cells and bacterial strains. This 
approach has the prospective to gain a better understand of BV other pathogens that may 
affect the vagina as well as have a research tool to develop new and effective treatment for 









Figure 2.11. EVATAR, a microfluidic representation of the female reproductive tract that contains compartments 
with different 3D cells culture from the ovaries, uterus, and the vagina. The liver is also included for the purpose 
of evaluating hormonal levels in response to drugs (Xiao et al., 2017).  
2.3 Scaffold Fabrication  
There are many techniques have been used to fabricate scaffolds for OOC devices which 
include photolithography, soft lithography, electrospinning, bio-plotting and 3D printing.  
2.3.1 Photolithography  
Photolithography sometimes known as optical lithography or UV lithography is a common 
process used in microfabrication to pattern designs onto a thin film called a silicon wafer or 
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other suitable substrates. Light is used to transfer specific geometric patterns via a photomask 
or an optical mask onto a photosensitive chemical photoresist spun on top of the wafer or 
substrate.  The photoresist is exposed to UV light to create the specific pattern for example a 
microfluidic channel. The photoresist then undergoes a series of chemical treatments which 
etches the patterns on to the material or deposits new material onto the pattern of interest 
depending on the material placed under the photoresist.  SU-8 is a common material used to 
fabricate microfluidic channels; un-crosslinked SU-8 is dissolved in a developer. Once the SU-
8 mould is fabricated on a silicon wafer, it can used repeatedly to fabricate several replicates 
of the design depending on the purpose of application. Though the process is well known it is 
a technique that requires specialised and expensive equipment, is time consuming and 
involves working with highly toxic chemicals. Even with these limitations it is still a technique 
that is commonly used especially in OOC application due to it being able to capture small 










Figure 2.12  Presents the step by step  process conducted in Photolithography to create precise and small masks 
known as SU-8 wafers for microfabrication applications (Verma et al., 2013). 
Photolithography is the most common method used to create moulds for OOC fabrication to 
form porous membranes made from PDMS. Huh et al, created flexible PDMS membranes for 
the lung-on--chip and gut-on--chip in which PDMS was poured onto the silicon master (SU-8 
wafer) that contained an array of microfabricated circular pillars with dimension of 10 µm in 
diameter and 30 µm in height. PDMS was carefully poured onto the wafer and spread evenly 
avoiding any air bubbles (Huh et al., 2013). The SU-8 master was also used to create the 
microfluidic channels as both the Lung-on-a-chip and Gut-on-a-chip channels were designed 
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to replicates the average diameter of an alveolus in human lungs and intestinal villus of the 
human gut.  
Though this method provides an ideal approach for creating membranes with small pore sizes 
for supporting the growth of 3D cell culture, the pores have shown to vary in size and 
thickness resulting in an uneven surface. This may be due to the handling of fabricating 
flexible porous membranes using PDMS. Though the PDMS membrane has shown promising 
results in both the lung-on--chip and gut-on--chip it has been reported that there are some 
varying results in terms of chip fabrication and testing. Small feature like the pores on the 
membrane varied in height. PDMS is also known to absorb hydrophobic molecules which 
could potentially compromise accuracy of drug efficacy and toxicity testing. This is due to its 
poor chemical resistance to certain solvents (Ingber et al., 2013). Furthermore,  it has been 
recommend that an alternative material can be used to create ultrathin porous membrane to 
mimic the extra cellular matrix (ECM) material that could be implemented in future OOC 
models (Ingber et al., 2013).   
2.3.2 Soft lithography 
Soft lithography is a fabrication technique that uses a combination of 3D printing, moulding, 
and embossing using an elastomeric stamp. The technique provides a low costing and 
convenient method to replicating a 3D design which is commonly used in microfluidics, cell 
biology, lab-on-a-chip applications (Qin, Xia and Whitesides, 2010). This method can also be 
used to create scaffolds to support tissue engineering applications in relation to OOC 
research. 
In soft lithography, the photolithography process is still being used to create pattern SU-8 
wafer to act as master (Figure 2.13). However, 3D printing is an alternative and easier method 
to create moulds with the desired design of interest which, can then be used repeatedly for 
creating elastomeric stamps. PDMS is cast over the moulds and left to set for 2-4 hours in an 
oven at 45°C or left to cure at ambient temperature for 24 hrs. PDMS is then removed from 
the 3D printed or SU-8 mould to reveal the embossed design and is then sealed against a 
suitable substrate i.e., glass or PDMS.  Soft lithography process uses a wide range of 
elastomeric material like PDMS, to capture the embossed structure from the master. This 










Figure 2.13. Presents the step by step process conducted in Soft lithography to create embossed elastomeric 
stamps made with PDMS (Microfluidics Background, 2020).  
2.3.3 Electrospinning  
Electrospinning is a process that uses electrostatic forces to draw polymer solution creating 
nanoscale fibrous structures. The fibrous structure can be used for various applications (Z.-M. 
Huang et al., 2003), including wound dressing (Khil et al., 2003; Min et al., 2004) tissue 
engineering scaffolds (Fertala, Han and Ko, 2001; Jin et al., 2002; Zong et al., 2003) and drug 
delivery platforms (Verreck et al., 2003; Ashammakhi et al., 2012).   
Electrospinning is a method that uses a high electrostatic field to draw a polymer solution, 
under a low pressure, from a needle tip to a metallic surface to create fibres.  A polymer 
solution is placed in a syringe, this is driven towards a needle tip through tubing by a syringe 
pump.  As the electrostatic field strengthen the Coulombic repulsion forces causes the droplet 
to change shape, this is called the Taylor cone.  
An increase in electrostatic strength causes a charged jet stream of polymer solution to eject 
from the apex of the Taylor cone (Reneker et al., 2000). The charged solutions travel in a 
vertical trajectory for a short distance, this is when the polymer solution goes through a liquid 
to a solid phase. The solution undergoes bending instability which results to further thinning 










Figure 2.14  Present the set-up of the electrospinning apparatus (Garg and Bowlin, 2011) 
Electrospun fibres contain unique characteristics which are ideal for tissue engineering and 
other biomedical application. This is due to the high surface area to volume or mass ratio and 
high surface area of pores varying in size (Choktaweesap et al., 2007). For tissue engineering, 
fibrous scaffolds are produced using biodegradable and biocompatible polymers. These 
membranes can be spun with a diameter ranging from microns to nanometres. Such small 
fibres can imitate the structural dimension of an extracellular matrix of tissue and organs 
(Huang et al., 2004). Human cells can attach and organise themselves around these structural 
membranes if the diameter of the fibres is smaller than the cells (Laurencin et al., 1999).  
There are several parameters that are considered for an electrospinning experiment such as 
concentration (wt. %), humidity (%), temperature (°C), voltage (kV), height (cm) and flow rate 
(mL/hr) (Laurencin et al., 1999). However, to be able to spin a biopolymer/polymer solution, 
there are five solution properties that must be considered which are conductivity, surface 
tension, solvent volatility, solution phase transitions and viscosity (Li and Wang, 2013; Teo, 
2015)  
Conductivity – Solvents selected for dissolving the polymer must have some conductivity. By 
increasing the conductivity of the solution, it has shown to improve the quality of fibres. By 
adding an organic or inorganic salt to spike the solution it can also lower the voltage required 
for electrospinning and reduces the formation of beads (Teo, 2015).  
Surface tension – The charged solution must overcome the surface tension of the solution. 
Surface tension reduces per unit mass of a liquid. Water has a high surface tension which 
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makes it difficult to electrospin causing the charged jet to form droplets or causes bead 
formation. By adding solvents such as acetic acid to water this reduced the surface tension 
and reduces the formation of beads producing smooth fibres (Teo, 2015).  
Solvent volatility – When the charged jet travels towards the ground collector, fibres are 
formed and solidified due to solvent evaporation. Using a low volatility solvent can cause wet 
fibres to be formed whereas using a high volatility solvent this can cause the solution to 
solidify at the tip of the spinneret (Teo, 2015).  
Solution phase transition – Is the interaction between polymer and solvent in terms of 
solubility at various temperatures (Teo, 2015).  
Viscosity – This is one of the main properties to consider for electrospinning as a high viscosity 
solution may not spin. This may be due to insufficient electrical charge to stretch the solution 
to form fibres. The solution concentration must be lowered to avoid gel like solution and have 
sufficient viscosity to be stretched into fibres (Teo, 2015).  
Gelatin, a natural biopolymer is derived from collagen, both have similar compositions and 
biological properties but dissolving gelatin in water is unsuitable for electrospinning. This is 
due to gelatin being a polyelectrolyte polymer and therefore needs treatment (cross-linking) 
with a high polarity organic solvent such as 2, 2, 2-trifluoroethanol (TFE) which allows gelatin 
to be directly spun into ultrafine fibres. It is known that collagen cannot be electrospun alone 
as molecular chains of collagen denature under strong solvents causing collagen to lose its 
native triple helical structure resulting in gelatin and therefore inhibiting collagen from 
electrospinning.  Therefore, blending with another biodegradable synthetic polymer such as 
poly (Є-caprolactone) PCL for the solution to be suitable for electrospinning is required 
(Laurencin et al., 1999).  
Zhang et al. produced gelatin nanofibers, however in order to improve the water resistance 
ability and thermomechanical performance for potential biomedical application, gelatin was 
crosslinked with glutaraldehyde (GTA) vapour for 3 days which preserved the fibrous 
morphology. The gelatin fibrous scaffold was placed into water at 37°C to check its stability 
and did not dissolve. The scaffold was used to study cell proliferation by culturing human 
dermal fibroblast for 1,3,5 and 7 days. Cells expanded over the duration of the cell culture 
experiments however, further cell expansion may have inhibited due to the cytotoxicity 
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residual of GTA left on the cells. This paper has shown that cell culture was successful on 
biopolymer membranes made from gelatin, but crosslinking is required to enhance the fibres 
thermomechanical and thermal stability performance (Yi, L et al., 2017).  
Huang et al investigated electrospinning gelatin dissolved in water, the solution was unable 
to produce fibres. TFE was used to dissolved gelatin which successfully produced nanofibers 
of 100nm – 340nm. Various solutions were made to spin from 5% - 12% w/v. Overall 7.5% 
w/v mass concentration gave the best results of electrospun fibres with an average size of 
140nm and no bead formation comparing to the other mass concentrations (Huang et al., 
2004). 
A newly optimised method has been observed in Horuz and Belİbağli paper where the L9 
orthogonal array and S/N ratio Taguchi’s method (effects four conditions flow rate, voltage 
applied, distance between tip and collector and concentration levels of acetic acid) was 
employed to find the optimal conditions for electrospinning gelatin with acetic acid. The 
experiments gave better (bead-free, smaller diameter and smooth) nanofibers (Horuz and 
Belibaǧli, 2017). 
2.3.4 Bio-plotting  
3D printing is a process that is becoming popular in the diverse areas such as medicine, 
aerospace engineering and tissue engineering. 3D printing is the process of building complex 
structures layer by layer, but it also can adopt various materials. It has been applied in tissue 
engineering research for building patient specific shapes with complicated porous designs 
such bone and ear cartilage, Figure 2.15. 3D printing involving cell is called 3D bioprinting 
which involves the construction of anatomy and physiology of desired tissues. This requires 





Figure 2.15. Presents images of 3D bio plotted constructs with heterogeneous and complex structures (A) a 
mandible of bone; (B) an ear cartilage with ear lobe; (C) a kidney with renal pelvis ;(D) a liver ;(E) a heart cross-
section and (F) an arterial tree (Yi et al.,2017). 
For 3D printing of OOC, biocompatible materials are available as printing ink, depending on 
the function and of the chip. The printing ink can be divided into two categories natural and 
synthetic. Natural materials such as collagen, gelatin, alginate and fibrin are formed by 
hydrogels also known as bioinks and are normally used to encapsulate cells in 3D cell printing. 
The bioinks are high in water content and viscoelastic which protects the cells during printing.  
Synthetic materials can adopt to any purpose for printing. Biocompatible synthetic polymers 
are normally low in cytotoxicity and bioinert, they are also stiff and rigid which makes them 
suitable for cell support framework for 3D cell -printing. 
Biocompatible polymers with non-degradable properties can ideally be used to 3D print 
housing components for an OOC. Materials such as PCL and PDMS can be used to print various 
parts of a device. Though PCL has biodegradable properties it can be used to print implantable 
devices that will last just over a year. Whereas PDMS, a silicon polymer is known for its 
flexibility and toughness that makes it useful to generate microfluidic devices which can be 
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used for cell culturing. PDMS is transparent which allows visualisation of cell culture or 
transporting of fluids. However, making PDMS chips can be an intensive process, but due to 
its reversible and irreversible bonding to glass and plastic and other materials it can be printed 
as an outer wall compartment as storage for cell media and hydrogels (Yi, et al., 2017). 3D 
printing of OOCs has shown the ability that this technique can be used to print such device, 
but this technology is at the preliminary stages and many aspects will need to be considered 
in the future for this process to fully develop into a working progress.  
2.4 Microfluidics 
Microfluidics refers to the behaviour of manipulating and precisely controlling fluids at a small 
scale ranging from microliters 10-6 to picolitres 10-9. It is a technique that is used through 
multidisciplinary fields from engineering, biology, nanotechnology to chemistry and 
biotechnology.  The use of microfluidics evolved during the development of lab-on-a-chip 
(LOC) devices which brought the likes of biology and chemistry research onto one single 
platform. With the support of technology such as 3D printing microfluidic devices can easily 
be fabricated, reducing the time it takes from a concept into a chip. 3D printing is the seen as 
the alternative method to conventional methods such as using SU-8 modelling (Fertala, Han 
and Ko, 2001). Stereolithography (SLA), Fused Deposition Modelling (FDM) and Material 
Jetting (MJ) are some of the most common 3D printing methods used to fabricate microfluidic 
chips.  
2.4.1 Stereolithography  
Stereolithography (SLA) is a form of additive manufacturing process that belongs to the 
photopolymerization family. The method of printing involves creating an object through 
curing a polymer resin layer by layer via ultraviolet (UV) laser beam. For SLA printing, materials 




As seen in Figure 2.16, the build platform is positioned in the tank containing the liquid resin 
which is set just above the surface of the resin. The SLA printer uses UV lasers to form the 
next layer by selectively curing and solidifying the photopolymer resin. Mirrors are placed at 
the corners of the build plate which determines the laser beam pathways.  
Figure 2.16  Present the set up for SLA printing which uses photopolymer and UV laser beam to build an object 
layer by layer (Fasnacht, 2017). 
The cross-section area where the model is being printed is scanned to ensure the part being 
printed is completely solid before moving onto the next layer. As each layer finishes the build 
plate gradually moves at a safe distance for the sweeper blade to recoat the surface. The 
sequence of steps is repeated until the print is finished. After printing, the prints are left to 
cure under UV light before being removed. Prints are solidified through the process of 
photopolymerization, as resin contains monomer carbon chains, these chains become active 
under the UV laser causing the material to solidify as it creates unbreakable bonds between 
each monomer chain (Varotsis, 2020b).   
SLA printers typical print height ranges between 25-100 microns, 100 microns being the 
optimum height for most applications. The build size is important depending on the SLA 
printer. There are 2 types of SLA setups: 1) top-down orientation and 2) bottom-up 
orientation. The top-down method places lasers above the tank where the build plate starts 
from the top and gradually moves down the resin vat as each layer is formed. The parts are 
built facing upwards, Figure 2.17. Whereas the bottom- up method the lasers are placed 
under the resin tank. The tank contains a transparent bottom coated in silicone which allows 
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the lasers to pass through and prevents the cured resin sticking to the bottom surface. As the 
build plate gradually moves up each layer is cured and detached from the bottom surface of 
the tank, this process is called the peeling step (Varotsis, 2020b). 
Figure 2.17 Demonstrates the Top-down SLA printer (Varotsis, 2020a). 
 
The bottom-up method is mainly used for desktop SLA printers like the Formlabs (Figure 2.18), 
which is easier to use and manufacture but the build size is limited due to forces being applied 
during the peeling step process which can lead to print failures, Figure 2.19. However, the 
top-down method is mainly used for larger scale prints which provides a greater accuracy in 
printing and faster built time but at a higher cos (Varotsis, 2020b). The main advantage of 
using an SLA printer is that it has the ability to fabricate parts with very high dimensional 
accuracy, in detail and provides a smooth finish. 
However SLA prints are not ideal for using as protypes as parts can become brittle and when 
exposed to sunlight or extreme heat can cause the prints to warp and change in mechanical 
















Figure 2.19 Demonstrates the bottom-up SLA printer (Varotsis, 2020a). 
2.4.2 Fused Deposition Modelling  
Fused Deposition Modelling (FDM) or Fused Filament Fabrication (FFF) is another additive 
manufacturing method that uses material extrusion as its main process. This printing method 
is often used to create basic prototypes for testing.  The FDM printer like the Ultimaker 2+, 
builds an object layer by layer as it deposits melted material on a defined pathway (Figure 















Figure 2.20 Ultimaker 2+ is an example of FDM printer, which uses filaments to build an object through material 




2.4.2.1 Method  
 
The FDM uses thermoplastic polymers in filament form. The filament is loaded onto the 
printer and nozzle is set to the desired temperature depending on the filament being used. 
The filament is the fed through to the extrusion head to the nozzle where the filament begins 
to melt. The extrusion head is connected to a 3-axis system which allows the nozzles to be 
moved in the x, y and z directions. The melted filament is extruded onto the build plate as 
thin strands and deposits layer by layer onto a predefined location where the layers cool and 
solidifies.  
Depending on the design, areas are usually filled by the extrusion head passing over multiple 
times. Once the layer is completed, the extrusion head moves up and deposits the next layer. 
This process in repeated which can be seen in Figure 2.21 until the designed part is completed. 
Support can also be added to the design to support the part during the building process. Once 
the print has finished the build plate is then left to cool down before removing the printed 






Figure 2.21 Presents the printing process of FDM (Varotsis, 2020a) . 
Usually, desktop FDM printers have a build size of 200 X 200 X 200mm whilst the printers 
used in industry have a build size of 1000 x1000 x 1000mm. FDM printer can print layers with 
a height ranging from 50-400 microns. Nozzles can be changed to refine the strands of 
filaments to increase the proximity of each layer creating a finer mesh. Layers printed at the 
optimum height of 200 microns provides a smooth finish with the ability to capture curved 
geometry. However, warping is known to be one of the major defects in FDM printing. This 
happens when extruded material cools during solidification which causes the dimensions of 
the layers to decrease. As areas of the print cool and solidify at different rates the dimensions 
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also change, resulting in layers to be pull upwards. To prevent warping monitoring the 
temperature of the build plate and increasing adhesion to the build plate is recommended 
(Varotsis, 2020b). 
The advantage of using FDM is that there is a wide range of material that can be utilised from 
commodity thermoplastic such as poly lactic acid (PLA) and acrylonitrile butadiene styrene 
(ABS) to engineering materials like polyamide nylon (PA), polyurethane (TPU) and 
polyethylene terephthalate glycol (PETG). For high performance, materials such as polyether 
ether ketone (PEEK) known for its excellent mechanical and chemical resistance properties 
that can also be used at higher temperatures are suitable for engineering applications that 
requires such properties. In comparison to other printing techniques FDM is the most cost 
effective method used to fabricate prototypes but is not suitable for creating moulds or 
designs with such intricate detail due to the high surface roughness after printing (Varotsis, 
2020a).  
2.4.3 Material Jetting  
Material jetting (MJ) is a forms of additive manufacturing process that runs in a similar way 
to a 2D printer. A print head similar to those used in inkjet printing distributes droplets of 
photosensitive material layer by layer, solidifying under UV light (Figure 2.22). MJ printers 
mainly uses thermoset photopolymer which include acrylics, ABS and transparent material 
which come in resin form. This form of 3D printing provides accuracy in dimensions and a 












2.4.3.1 Method  
To operate MJ printing, first the resin is heated to temperature of 30-60 °C for the resin to 
reach optimum viscosity. The printer head then travels over the build plate where it deposits 
several tiny droplets on a designated location. A UV light source is attached to the printer 
head which solidifies the material creating the first layer of the print. Once a layer is 
completed the build plate moves down as each layer builds. This process repeats until print is 
complete (Figure 2.23). With MJ printing, the support structures are always included in the 
print. The support material is easily removed or can be dissolved leaving a smooth finished 
print. Both MJ and SLA methods use photosensitive polymers that undergo 
photopolymerization to solidify the material, however MJ printers do not need further post-
curing to achieve optimised prints due to the small height of 16-32microns being used to print 







Figure 2.23. Presents the printing process MJ printing (Bournias Varotsis, 2019). 
MJ method is one of the most accurate addictive manufacturing methods amongst other 3D 
printing methods. The printer has a dimensional accuracy of ± 0.1% with a typical lower limit 
of ± 0.1 mm. Sometimes parts printed using this method can experience warping, but it is not 
as common as SLA and FDM because MJ usually prints at room temperature making it easier 
to build larger parts with greater accuracy. However, MJ prints are suitable for non-heavy use 
due to poor mechanical properties and degradation of material over a period of time. 
2.4.4 Lego Microfluidics  
In most OOC devices the alignment of the layers has never been expressed in detail though 
this is seen as an integral part to the OOC design. Alignment aids the combing of individual 
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layers into one working device as channels, inlets and outlets must be aligned correctly to 
avoid faulty chip. If any of the layers are misaligned during the assembling process, this can 
cause the chip to not function properly causing issues, like leakage, the attachment of tubing, 
inserting of membrane and bonding between layers. 
 It is vital that alignment is checked during the design process before chips are fabricated for 
prototyping. Fail to identify the misalignment can be costly, time consuming and waste in 
materials and resources. Vittayaraukskul and Lee’s (2017) paper discussed Lego® like modular 
microfluidic platform by using Lego® like designs to mass produce simple 3D microfluidic 
devices (Figure 2.24). The idea was to promote the reversible pressure sealing as well as 








Inspired by this concept of the automatic alignment feature, alignment posts will be 
implemented on the design of the VOC platform. With this feature the layers will be easy to 
assemble and detached for further experimental use. The alignment posts will provide an 
interlocking system similar to Lego®. This will benefit the chip by providing better layer 
attachment and sealing between layers.   
2.5 Summary   
After conducting a thorough literature review on the previous and current studies done 
regarding female health care for the treatment of BV and there is no model that only models 
the vagina or a system that can host the innate response to understanding what causes BV 
and how it can be managed to reduce the chances of recurrence. Therefore, a gap has been 
Figure 2.24 Fluid flow through microfluidic Lego® (Vittayarukskul and Lee, 2017). 
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identified in the knowledge. To create a device that can be used to understand BV and to find 
better treatment to improve female health.   
The following objectives will be considered in this thesis: - 
1. Microfluidics: To develop a new organ-on-a-chip device for the study of BV: 
 
By using microfluidic techniques and 3D printing (material jetting) to design and create 3 
layered VOC platform that will house a biocompatible membrane held in suspension to 
support the growth of squamous epithelial cells. The VOC will consist of microfluidic channels 
designed to provide nutrients to the cells. The platform will be attached to an automated 
system that will control and monitor flow and pressure for testing and to stimulate the 
environment of the human vagina.  
 
2. Electrospinning: To create a porous biocompatible and biodegradable membrane onto 
which different cell types can be seeded and proliferate. 
To create functional, physiological vaginal micro tissues within the device - creating 
biocompatible, stretchable porous membranes using electrospinning technique which will act 
as a scaffold to support the growth of 3D vaginal epithelium tissue.  The membrane will be 
made with synthetic and natural biodegradable polymers such as gelatin, collagen and 
polycaprolactone.  Immortalised epithelial cells line VK2/E6E7 will be seeded on to the 
membrane and cultured for short- and long-term experiments on membranes alone and 
within the chip to establish vaginal tissue. The microfluidic channels on top and bottom will 
distribute growth media to cells continuously. Live/dead cell assays and fluorescence 
microscopy will be used to validate cells. 
3. Cell culture: To create 3D vaginal tissues in vitro.  
To seed bacteria associated with the normal microflora and bacterial vaginosis.  Lactobacillus 
Spp. species will be added to the vaginal epithelial cells to identify the optimal percentage 
required for cells to grow which will then be added to the VOC to mimic the human vaginal 
microbiome. This can then be compared as a healthy model vs unhealthy model that is seeded 
with BV bacterial strains. 
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Chapter 3 – Microfluidic Design of the VOC platform 
and fabrication processes 
 
OOC platforms are seen as one of the latest emerging technologies to capture the attention 
of biomedical research worldwide. They are addressed as biomimetic systems developed on 
microfluidic chips that combine multidisciplinary research in engineering, cell biology, 
microenvironments, and biomaterials to stimulate the tissue - tissue interactions and 
mechanical stimulation of the organ of interest. The platform provides an insight to the 3D 
structural and functional characterisation of human physiology and its environment (Sun et 
al., 2020; Wu et al., 2020). These OOC platforms are the development of a novel approach for 
in vitro disease modelling, to study complex human diseases and conditions which can then 
be used to produce new drugs and treatment, testing of toxicity (drugs and chemicals) and  
potentially an alternative method to animal testing (Huh et al., 2013). The main purpose for 
the development of the VOC platform was to create a realistic model that truly represents 
the function and physiology of the human vagina and its environment to gain a better 
understanding of bacterial vaginosis. To create and manufacture an OOC platform design 
requirements and engineering principles must be considered  before fabricating such a 
complex device which can be a challenging process (Yang, et al,., 2017). Figure 3.1. shows the 










In the previous chapter a thorough literature review was conducted to identify the previous 
and current models used to study vaginal epithelial tissue as well as OOC models that have 
been developed to study organs of interests including the lungs, liver and gut. However, the 
literature indicated the lack of OOC devices that have successfully cultured 3D cells with their 
natural microbiome. The gut-on-chip is currently the only model that has shown promising 
results in studying the interactions between the host cells and its natural microbiome.  With 
reference to this model the VOC platform has been designed to support the development of 
3D vaginal tissue and to include the vaginal microbiome, to create a realistic in vitro 
environment. Once established, the VOC platform has the potential to investigate the 
initiation, progression, and treatment of bacterial vaginosis.  
3.1 Engineering Design Process 
To create the VOC platform an engineering design process was followed seen in Figure 3.1 to 
identify the design requirements for the VOC platform.  
Define the Problem: - As discussed, BV is a common vaginal infection that affects women of 
childbearing age and if left untreated can lead to complication such as premature births, 
miscarriages, and pelvic inflammatory disease. The vagina contains a natural balance of 
healthy bacteria Lactobacillus spp., which promote the production of lactic acid; these 
bacteria are responsible for maintaining a low the pH of the vagina. However, when this 
environment becomes disrupted infections like BV can occur due to an overgrowth of 
anaerobic bacteria. Therefore, a novel approach must be considered to understand the 
complexity of BV and how it could help develop new and improved treatment of the infection.  
To construct the VOC platform, different type of materials and methodology must be 
considered. 3D printing and soft lithography will be used to make the layers of the VOC 
platform using PDMS. The device must also contain a membrane made from biodegradable 
material that is porous, biocompatible and exhibits good mechanical properties to support 
the growth of vaginal tissue. Electrospinning technique will be used to fabricate such 
membranes using biopolymer and synthetic polymers to form ultrafine fibres mats with 
multiple arrangements and morphological structures. These fibres usually have a diameter 
ranging from micrometres to nanometres. The fibrous mats provide features like porosity and 
large surface area ideal for application like wound dressing, drug delivery applications and 
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tissue engineering. In this research the electrospun mats will be used as scaffolds to support 
the growth of vaginal tissue at the centre of the VOC platform.  
The VOC platform embodies the function of vaginal tissue; therefore, the type of cells that 
will be utilised in this platform must be considered for modelling an in vitro system to mimic 
the in vivo behaviour. To fully mimic the vaginal environment the microbiome of the vagina 
must also be included in the design of the platform. This is so to establish a healthy system 
that truly represents the human vaginal environment where bacteria induce the biofilm 
formation on the epithelium membrane.  
Plan Solution: - To design and develop a novel 3D microfluidic tool, VOC, which can be used 
as a research tool to investigate the initiation, progression, and treatment of BV, by combing 
multidisciplinary techniques that will mimic the mechanical, biochemical and physical aspects 
of the vaginal tissue. The main aim is to create a viable VOC platform to study the factors that 
cause an interruption in the vaginal microbiome and the interaction between the vaginal 
epithelial cells and bacteria strains, to improve female healthcare. 
Design and Create Model: - The designs behind the VOC platform were derived from the lung-
on-a-chip, Liver-on-a- chip and gut-on-a-chip with a similar concept of channels crossing over 
each other whilst being separated by a semi permeable porous membrane. The use of 
multiple techniques such as 3D printing, soft lithography, microfluidics, and electrospinning 
were used to fabricate the VOC platforms which is described further in methods section 3.5.  
Test and Analyse: - VOC designs were tested using a Fusion 200 two channel syringe pump – 
(KR Analytical, UK) with green and blue food colouring dyes to check and analyse the 
performance of the chip design, the alignment of the layers, the bonding between the layers 
and positioning of the membrane. A steady flow rate of 15 µL/hr was used replicate the 
dynamic flow that is experienced by the cells and tissues in the vagina.  
Reflect and Redesign: - From the analysis conducted through the experimental stages of the 
VOC experiments, results were then analysed to identify any challenges. Once identified, the 
process of re-designing and further iterations were conducted, re-tested and analysed, until 
the final design had been optimised and met the desired design requirements of a fully 
functioning device.  
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3.2 Design Concept 
The aim of the VOC is to create a realistic platform that truly represents the human vagina 
and its microbiome environment. The VOC design consists of three layers (Figure 3.2). The 
top and bottom layers feature the fluidic channels, designed and positioned to flow over and 
under the central layer, to provide continuous supply of nutrients to the vaginal cells grown 
at the centre of the chip. The central layer consists of a biocompatible membrane, fabricated 
using the electrospinning technique, seen in chapter 4. The VOC has been designed to support 
and hold the membrane in suspension like a gasket which forms the middle layer of the VOC 
platform. The purpose of the electrospun membrane is to mimic the natural ECM for vaginal 
epithelial cells to grow and form 3D vaginal tissue. The platform contains two microfluidic 
channels, to support the future prospects of using more than one cell type. For the first VOC 
prototype VK2/E6E7 vaginal epithelial cells will be used. All components of the VOC are 
fabricated individually and then amalgamated into one single platform as seen in Figure 3.2. 
Figure 3.2 Concept design of the VOC platform. 
3.3 Product Design Requirements  
Currently, OOC devices that have been established in the market have not been created under 
any official International Organisation for Standardisation (ISO). Therefore, there are no 
specific requirements to designing the ideal OOC platform. However, from literature common 
principles such as the design, materials and size have been taken into consideration to 
develop the VOC. Table 3.1 presents the design requirements for the VOC and how these 
measures will be used to develop and manufacture and working design. 
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Table 3.1 Design requirements for the VOC platform. 
Design Requirements 
Design Dimensions Reason 
Size of chip 
Length 75 mm 
Width 25 mm 
The size of a glass slide, for ease of 
handling the chip during testing. 
Ideal for microscopy evaluation.  
Size of channels 
Length ~ 10 mm 
Width 2.75 mm 
 
 
Large channels to provide nutrients 
to the cells at the centre of the chip. 
First design to work at macroscale 
once optimised can be scaled down 
to microscale.  
Size membrane 
Length ~ 20 mm 
Width 8 mm 
 
To provide the cells a large surface 
area to grow. Also, to obtain a 
sufficient sample for further testing. 
Small electrospun membrane can be 
difficult to handle therefore, a 
realistic sample size can be easier to 
manufacture and handle during 
assembling of the VOC platform.  
Size of in/outlets 1 mm diameter 
To ensure tubing can be attached to 
the 3D printed mould securing a tight 
seal between the tubing and the 
layer of the chip. When PDMS cures, 
the tubing will then be attached to 
the layer of the chip. This method will 
prevent the tubing from detaching, 
blocking, and leaking.  
Lego alignment posts 1.50 mm diameter 
For the alignment of the different 
layers. This will help with the 
alignment of the channels over the 
membrane. The post will help with 
the sealing of the chip as well as 
provide the flexibility in detaching 
the layers to obtain samples for 
further testing. The post will provide 
a plug and play system have Lego® 
bricks use.  
51 
 
3.4 Materials  
The following equipment and materials were used to fabricate the VOC chips.  
Poly(dimethylsiloxane) (PDMS) (Qsil 216, ACC Silicones Ltd, UK), 3D printed moulds made 
from VeroWhite resin (Stratasys, US), Steel casing (Brunel, UK), 
Polytetrafluoroethylene (PTFE) tubing 1.58mm OD x 0.5mm ID (Sigma Aldrich, UK), Silicone 
tubing 0.5mm OD X 1.00mm ID (Atlec, UK), Isopropyl Alcohol (IPA), nitrogen gas, Corona 
Plasma Treater (BlackHole Lab, FRA), Fusion 200 Two channel syringe pump (KR Analytical Ltd, 
UK) , Syringe (BD Plastics, UK), Blunt needles End 22G (RS, UK) and electrospun membranes 
(see chapter 4).  
3.5 Methodology 
To design and develop the VOC platform, SolidWorks 2017 was used to draw and design the 
VOC moulds. These drawings were then converted, and 3D printed into moulds. The soft 
lithography method was then used to create the individual layers of the VOC. This method 
was selected as it is cost effective, captured micron-scale features, easy to fabricate and 
manufacture chips for prototyping, further details can be seen in section 3.5.1-3.5.3. 
3.5.1 PDMS for fabricating VOC layers  
PDMS is a flexible elastomer silicon based organic polymer that is often used in prototyping 
and testing microfluidic applications including lab-on-chip (LOC) and OOC devices. PDMS is 
normally selected as the ideal material for such applications  due to its versatile properties of 
being biocompatible, cost effective, permeable for gas exchange and optically transparent 
(Charati and Stern, 1998; Marois and Be, 2001; Leclerc, Sakai and Fujii, 2003).  
PDMS is also easy to use and is excellent for moulding, but one key feature is that it has the 
ability to bond irreversibly to glass or onto itself. This is done by activating the surface with 
plasma treatment to form a permanent bond (Haubert, Drier and Beebe, 2006). However, to 
ensure good bonding between any surfaces i.e., glass or PDMS all surfaces must be clean. Any 
dust or contaminant on the surface can hinder the bonding effect which can lead to many 
issues, for example leaking between layers and incomplete bonding during experiments.  
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3.5.2 Soft Lithography Process for Creating VOC Moulds  
The process of soft lithography which consists of using a 3D printed mould or an SU-8 wafer 
discussed previously in chapter 2 which can be used multiple times to manufacture 
microfluidic chips.  PDMS was selected as the main material for creating the VOC layers due 
to the many benefits it provides as mentioned above (3.5.1.) To make the VOC layers the soft 
lithography process is followed as depicted in Figure 3.3. The moulds are used as stamps.  
PDMS is then poured on top of the moulds and allowed to set for a required time. Depending 
on the size of the mould and the volume of PDMS used, curing time for PDMS can vary 
between 2-4hrs in the oven at 45°. Once the PDMS has cured, the PDMS layer is then slowly 
removed to reveal the negative print of the positive mould (step 3 of Figure 3.3). This is a 
favourable technique often used in microfluidic fabrication, due to being a cost-effective 
process. This method was used successfully to make the individual layers of the VOC platform 


















PDMS left to cure at 45° C 
in the oven for 2-4 hrs 
PDMS  
Mould   
Positive Stamp  
PDMS  
Mould   
Negative PDMS layer peeled 
off from the positive stamp 
(mould) 
Figure 3.3 Schematic illustration of the three major steps involved in the soft lithography. 




Mould   
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3.5.3 Design and Fabrication of VOC Moulds  
To create the VOC platform, moulds were first designed using computer aid design software 
(CAD) SolidWorks 2017 and saved as stereolithography (STL) files.  The designs were then 3D 
printed using the Objet 30 to create the VOC moulds. Polyjet, also known as material jetting, 
is a form of 3D printing that uses a photosensitive polymer resin i.e., VeroWhite. Designs were 
printed layer by layer and then solidified using ultraviolet light (UV) resulting in a rigid and 
highly detailed print. The method was chosen to create the moulds as it provides prints with 
a smooth surface finish and captures the micron- scale features in the design. With a smooth 
surface finish, PDMS layers are easily removable from the mould. The resulting smooth 
surface of the PDMS layers also provides an improvement in the bonding between layers.   
3.5.4 Assembling VOC Moulds into Steel Casing 
To make the VOC PDMS layers, 3D printed moulds were enclosed into a steel casing seen in 
Figure 3.4 and sealed with M8 screws. The casing was designed and made to fit the VOC 
moulds with a dimension of 30 x 80 mm whilst providing a final chip dimension of 25 x 75 mm. 
Moulds were cleaned with Isopropyl Alcohol (IPA) followed by rinsing with deionised water 
(DI) and left to dry. To ensure moulds were contaminant free the moulds were left under the 














Figure 3.4 Full casting assembly of VOC mould housed in a steel casing to fabricate 
the PDMS layers of the VOC platform.  
VOC mould 
Steel casing outer 
dimensions 30x80mm 
inner dimension 25x75 
M8 Screws to 
seal the mould 
within the 
casing   
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The custom-made steel casing undergoes the same cleansing treatment to avoid 
contamination.  The mould is then placed into the steel casing and is tightly sealed to ensure 
no leakage of PDMS. Nitrogen gas is then used to remove any dust particles on the surface of 
the mould, this is to ensure a clean surface before adding PDMS to the moulds. The top steel 
plate has a depth of 2mm to create 2mm thick PDMS layers for the top and base of the VOC 
platform. Another steel casing was used to make 1mm thick PDMS layers to make the central 
layers that would support the membrane held in suspension. See appendix for full engineering 
drawings of steel casing for the VOC moulds.  
3.5.5 Preparing PDMS mixture  
To prepare the PDMS for the VOC moulds, a 1:10 (mL) ratio of Part QsilA: QsilB (ACC Silicones, 
UK) were measured to a final volume of 20mL and manually stirred for 3mins. The PDMS 
mixture is then placed into a vacuum desiccator and degassed for approximately 20mins until 
all air bubbles have been removed, leaving a clear viscous solution (Branavan et al., 2016). 
For the top VOC mould tubing of 0.5mm OD X 1.00mm ID (Atlec, BEL) was added to the inlets 
and outlets, this is so the tubing would attach to the PDMS whilst curing, creating a tight seal 
to avoid leakage at the inlets and outlets during testing; a problem commonly encountered 
in microfluidics (Figure 3.5). The desired mould is usually cleaned and sterilised before 
securely enclosing the mould into the steel casing. The PDMS is then carefully poured on top 
of the mould at close proximity to avoid creating additional air bubbles. The moulds are 
placed into an oven at 45°C for 2-4 hours for the PDMS to cure. Due To the moulds being 
fabricated in VeroWhite material, the moulds can only withstand a maximum temperature of 
50°C, if exceeded the moulds’ physical form alters significantly due to the low glass transition 








Figure 3.5 Tubing attached to the in/outlets of the 
top layer for a secure connection. 
Tubbing attached to the 
in/outlets of the two 




3.5.6 Removing VOC PDMS layer of moulds  
After 2-4 hrs of curing time, the PDMS layers are then ready to be removed from the moulds. 
The casing with the moulds is removed from the oven and left to cool at room temperature 
for 2 mins, before disassembling. Once cooled, the moulds are gently pushed out of the 
casing. Using a scalpel, the PDMS layer is then scored at the edges to remove any excess 
material. To ease the removal of the PDMS layer off the moulds, the edges of the cured layer 
are gently squeezed a few times to enable detachment from moulds. The PDMS layer is then 
slowly removed to avoid tearing and carefully stored in a petri dish for plasma treatment.  
3.5.7 Bonding of the VOC PDMS layers  
To form the layers of the VOC platform, PDMS layers were treated using a handheld corona 
(BlackHole Labs, FRA). The plasma treatment was applied for approximately 2 mins across the 
surface of the layers that require bonding.  Plasma treatment is a method used extensively in 
microfluidic fabrication. The treatment is mainly used to clean the substrate of contaminates 
and for bonding. By activating the surface of PDMS, the process alters the properties causing 
PDMS change from hydrophobic to hydrophilic state.  This then allows the surface to bond 
with other treated surfaces. 
PDMS is made from repeating units of (C2H6OSi) n, but when treated this causes plasma to 
form free radicals which modifies the surface by removing the hydrocarbon groups and 
exposing silanol groups (-OH) at the surface of the PDMS. This results in strong covalent bonds 
(Si-O-Si) between PDMS and glass or PDMS to PDMS (Figure 3.6). This surface modification 
provides strong conformal bonds between surfaces that when oxidised,  surfaces brought in 
to contact can cause irreversible bonding  which occurs between the PDMS-PDMS layers (Tan 
et al., 2010; Pasirayi et al., 2012). 
 
Figure 3.6 Surface modification of PDMS after oxygen plasma treatment (Pasirayi et al., 2012). 
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As each layer of the VOC was treated, the individual PDMS layers were placed in descending 
order starting with the VOC base, central base, electrospun membrane, central top and finally 
the top layer to form the VOC platform, assembly of the VOC platform can be seen in 
Appendix A, 9.7.1. The final VOC platform was left in the oven over night at 45°C to ensure 
sufficient bonding between each layer before testing.   
3.6 Design iterations and evaluation 
Below discusses the design iteration and evaluation conducted on the VOC platform designs. 
Each design was tested, evaluated and re-designed to produce the final platform. A summary 
of the evaluation process can be seen in Table 3.2.  
3.6.1 Initial Design  
The initial VOC model contained two microfluidic channels and alignment posts placed at the 
corners of the moulds to assist with assembling of the VOC layers (Figure 3.7). This design was 
carried out to evaluate, analyse, identify the challenges of the design and how a third layer 
could be introduced to the system i.e., the membrane which would be held in suspension 
between two fluidic channels to form the VOC model. From this, changes were made, further 
design iterations tested and analysed until the optimal design was achieved. Table 3.2 
provides a summary of the different VOC designs outlining the design features, advantages, 
disadvantages and the benefits that were drawn and reflected on, to optimise and create the 









Figure 3.7 Initial concept of the VOC design mould with fluidic 
channel and alignment posts at the corners of the mould.  
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Table 3.2 Summary table of the VOC designs presenting the features, evaluation and benefits of each design.  
Summary of VOC Designs 
Design No. Design Design Features  Evaluation  Benefits 
2 
 • Membrane holders (0.5 x 19.50 mm) 
added on either side of the membrane to 
hold the membrane in suspension 
between the two fluidic channels to 
create the middle layer of the chip.  
• Size of holders were too small, causing the 
electrospun membrane to slide and not 
hold in place, resulting in sagging of the 
membrane and leakage of coloured 
solution into bottom channel. 
• Third layer is created. 
• Membrane holders ideal feature 
to hold the membrane but need 
to increase the width to avoid 
sliding and leakage.  
3 
 • Membrane holders (1 x19.50 mm) 
increase in width to provide support for 
the membrane held in position at the 
centre of the chip. 
• The increased width of the membrane 
holder held the membrane in place, but 
still experienced sagging and sliding of the 
membrane. In/outlets had a small orifice 
for tubing attachment which often led to 
blockage.  
• Increased width of the membrane 
holder improved the performance 
of the chip slightly, by holding the 
membrane in suspension.  
 4 
 • Diameter for the in/outlet increased from 
Ø0.5 to Ø1.0 mm to improved 
attachment of tubing 0.5 mm OD X 1.00 
mm ID (Atlec, UK ), for flow experiment.  
• Adding the tubing to the in/out lets of the 
mould, ensured tubing was attached to 
the PDMS layers, making it easier to run 
flow experiments.  
• Reduce blockage. 
• Tubing attached to the mould to 
secure bonding of tubing to the 
in/outlets of the channels. 
• Avoid leakage around the 
in/outlets 
5 
 • Layer added around the channels to seal 
the opposite channel during bonding, to 
prevent leakage into the opposite 
channel.  
• The extra layer increased the depth of the 
channels which was not necessary. The 
chip was set to have 1mm depth channels. 
• To ensure opposite channels were 
sealed. 
• Reduce the sagging effect of the 
membrane exposing the channels  
6 
 • Posts added to the membrane holders to 
sandwich the membrane in position 
between the layers. 
• Due the small area on the membrane 
holders, the post accumulated space 
preventing the membrane from being 
held in place. 
• Removing PDMS from small features 
proved tricky as PDMS would get stuck or 
tear, damaging the layers.  
• Design discarded but, inspired the 
creation of a gasket layer 
containing the membrane holders 
to support the membrane. 
• Top and bottom layers would 
consist of the fluidic channels 
only, to simplify the design.   
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3.6.2 Design 7 – The Final Model  
To develop the final model, a performance evaluation of the previous designs was 
undertaken, taking into account the positives and negatives of each design using Table 
3.2 as a reference. The novel design comprised of four moulds, that when combined 
would create the three layers of the VOC platform. The top and bottom moulds (Figure 
3.8 A and B) contained the fluidic channels that would flow over and under the 
membrane based at the centre of the final chip. Expanding on the idea of design 5 (Table 
3.2) two moulds were made to create the gasket layer (Figure 3.8 C and D). This layer 
was designed to support the membrane held in suspension at the centre of the chip 
between two fluidic channels. It also prevents sagging of the membrane and leakage 
into opposing channels. The idea was to sandwich the membrane as the middle layer of 
the VOC platform. The gasket layer not only seals the channels when layers are 
combined but, has been designed to cover the exposing areas of the channels at the 
meeting point of where the channels align with the membrane area at the centre of the 
chip. Moulds were all 3D printed in VeroWhite with an outer dimension of 30 x 80 mm 
to fit into the steel casing and with an inner dimension of 25 x 75 mm which resembles 
the same size of a glass slide. All four moulds included the alignments posts to aid with 




Figure 3.8 Presents the SolidWorks and 3D printed moulds for the VOC platform (A) Top VOC mould; (B) Base VOC 




3.7 Assembling of VOC platform 
To create the final VOC platform, each layer is stacked on top of one another to create 
a complete model. In total, there are 5 individual layers of the platform that create the 
three main layers of the VOC as demonstrated in Figure 3.9. Top VOC layer (A) 
represents the first layer, central top layer (B), electrospun membrane (C) and central 
base layer (D) combined together form the middle layer and finally the base VOC layer 
(E) represents the final layer. Figure 3.10 illustrates the final assembly of the VOC layers 












Figure 3.10 Final assembly of the VOC platform from a top view and isometric view with the 
membrane at the centre held in suspension between the channels.  
Figure 3.9 Final VOC platform in exploded view showing the separate layers in order (A) Top 
VOC layer; (B) Central top layer; (C) Electrospun membrane; (D) Central base layer and (E) 









3.7.1 Channel Dimension  
 
The VOC platform prototype was designed to resemble the width and length of a 
microscopic glass slide 25x75 mm for easy handling of the platform. The channels 
dimensions have been designed with a width size of 2.75mm and height of 1mm 
(Appendix A, 9.1). Dimensions are large in scale when compared to the width and height 
of the channels for both the lung-on-chip and gut-on chip which have channels 
dimension of (400µm x 100µm). The VOC was designed to allometric scale with larger 
channels to provide sufficient nutrients to the membrane. The channels meet at the 
centre of the chip where the membrane is located (Appendix A, 9.1).  A wider opening 
of the channels near the membrane will provide a dynamic flow of media to cells to 
mimic similar conditions that cells experience on a daily basis. 
3.7.2 Top and Base VOC Moulds  
Both the top and bottom VOC moulds have the same dimensions however, the top VOC 
mould contains extra in/out lets circled in red, Figure 3.11(A). The extra in/out-lets 
provides an access point for tubing to be inserted from the top layer. This allows the 
tubing to connect the top layer to the base layer to provide nutrient flow to the base 
nutrient channel. It is important that the layers are aligned properly for the tubing to 






The membrane area 8 X 19.50mm seen in Figure 3.11 (A and B) was design in such a 
way to provide a larger surface area for 3D cell culture. Unlike other OOC model that 
mainly uses PDMS as the porous membrane, the VOC contains an electrospun 
membrane made from bio and synthetic polymers fabricated to support the growth of 
3D vaginal tissue. However due to the thickness of the membrane with an average 
A B 




depth of 0.2-0.7mm, being light in weight, it can be quite difficult to handle the sample 
manually. Therefore, a large membrane sample was required for easy assembly into the 
device as well as provide a large surface area for cell attachment.  
3.7.3 Central top and base membrane layers  
To support the membrane in suspension the central top and base layers were designed 
as a gasket layer. The gasket layer also ensured the separation of the fluidic channels. 
As the nutrient channels cross over each in opposite directions, the central and base 
membrane layers provide sealing of the top and bottom fluidic channels when bonded 
to the middle layer of the platform. The also prevents leakage of nutrients into opposing 
channels. The central base layer contains membrane holders with a width and depth of 
0.5mm on either side of the membrane area seen in Appendix A, 9.2.1 and 9.3.1 The 
electrospun membrane is placed between the central top and base and sealed by 
bonding, forming the middle layer of the VOC model.  
 
3.8 Testing of VOC platform  
Initial testing of the VOC platform was conducted using blue and green colour dyes using 
the Fusion 200 two channel syringe pump (KR Analytical Ltd, UK). 5mL of dye was added 
to 15mL syringe (BD plastics, UK). Blunt 22G needles with an end of 0.5” were attached 
to the syringe via the Luer lock and silicone tubing 0.5 mm OD X 1.00 mm ID (Atlec, BEL). 
To connect the silicone tubing to the chip, 1cm of Polytetrafluoroethylene (PTFE) 
tubing, 1.58mm OD x 0.5mm ID (Sigma Aldrich, UK) was placed into the inlet and outlets 
of the chip. The syringe pump was set at a flow rate of 15 µl/hr to produce a laminar 
flow that would mimic the dynamic flow cells and tissue would normally experience in 
the body. A steady flow rate was selected to prevent the chip from leaking, layers 
separating and cells from detaching from the surface of the membrane.  
Figure 3.12 presents three individual VOC platforms and how the platform appears in 
three stages; (A) the VOC platform without the membrane, to visualise the channels 
positions on the chip; (B) the VOC platform with an electrospun membrane at the centre 
of the chip separating the top and bottom fluidic channels and (C) the outcome of the 
flow experiment conducted with both blue and green dyes passing through the 
channels. The membrane is held in suspension with no sagging or mixing of the fluidic 
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in opposing channels. However, leakage of the blue dye can be seen on the top layer, 
this may be due to partial bonding around the channels. The VOC is a working prototype 
at preliminary stages of testing which was tested by conducted wet experiments. 
Computational fluid dynamics (CFD) simulation but was not conducted on the prototype 
due to time constraints, but simulations would be beneficial for future experiments. 
With simulations, challenges can be predicted, designs optimised and reduce material 












3.9 Summary  
The main aim of the VOC platform design requirements was to contain a layer that 
would hold the membrane in suspension to support 3D cell culture. The VOC was 
designed to contain 3 main layers, two microfluidic channels and an electrospun 
membrane. The model also included alignment post to help with aligning of the 
layers. Alignment post features have never been used on an OOC device, but as the 
VOC contains multiple layers, it was essential to include these markers assist with 
alignment of the layers. The VOC design went through seven iterations (Table 3.2) to 
reach an optimised design for the final moulds that would be used to fabricate the 
VOC platform.  
In Figure 3.9, layers of the VOC were shown in an exploded view to demonstrate the 
order of layer fabrication. The VOC, being at its preliminary stages of prototyping was 
A B C 
Figure 3.12 Three independent VOC chips (A) an empty VOC platform; (B) VOC platform 
with membrane between the two fluidic channels and (C) flow experiment conducted 




designed in the allometric scale i.e., microfluidic channel with a height of 1 mm and 
width of 2.75mm in comparison to  the Lung-on-chip that has a channel size of 1mm 
in width and final chipsize of 25 x 40 mm (Huh et al., 2013). This was done to ensure 
nutrients were provided tothe cells at the centre of the chip. The membrane area also 
contained a larger membrane sample of 8 mm x 19.50 mm ensure there was sufficient 
cell embodiment on the membrane as well as provide a large sample for further 
testing i.e., sample biopsies.  
The channel height and membrane area of 1mm height was selected to provide 
enough space for 3D cell culture. The wider channels minimise the shear stress that 
cells may experience during the flow experiments. The role of the membrane holders 
which for the gasket layers was design to support the membrane in suspension 
between the fluidic channels but, also provided space between the channels to 
support 3D cell culture. As the membrane is porous, this would allow the cells to 
infiltrate the membrane by gaining support from the surrounding fibres and 
eventually forming vaginal tissues.  With a larger surface area for cell adhesion, the 
VOC platform would provide larger samples to conduct statical data analysis.  
The size of the VOC platform was designed to have a final dimension of 25 mm x 75 
mm corresponding to the same size of a glass microscopic slide. This made it easier 
to manually handle the platform during experimentation. The platform underwent 
initial testing with colour dyes to observe the performance of the design, alignment 
and bonding of the layers. The next stages of testing would be to introduce the cells 
to the final VOC system to evaluate it performance, whether the VOC has the ability 
mimic the function of to form 3D vaginal tissue. This test would then be carried out 
using the Elveflow system, a system designed to controlled flow and pressure within 
the VOC. Once establish further, the system could then be challenged with bacterial 





Chapter 4 – Electrospun Membrane Fabrication 
and Evaluation 
Electrospinning has been recognised as an effective technique to fabricate polymers 
into ultrafine fibrous mats. Due to their fibrous characteristics, they are commonly used 
as scaffolds to support various biomedical applications which include wound dressing, 
tissue engineering and drug delivery platforms (Z. M. Huang et al., 2003). 
Electrospinning has been around since the 1930’s and was mainly used in the textile 
industry to manufacture non-woven fibres. However, over the years the procedure had 
become increasingly popular especially in biomedical research, as  polymer solutions 
and parameters were easily adjustable in developing scaffolds for tissue engineering 
applications (Kim et al., 2009). The technique has the ability to produce electrospun 
mimic the structure of ultrathin fibres with a diameter than mimics the  extra cellular 
matrix (ECM) (Kim et al., 2009; Cipitria et al., 2011). It also delivers a large surface area 
which, favours cell attachment and due to its porosity characteristics. This allows the 
scaffolds for the exchange of nutrients and waste material, ideal for drug loading 
applications (Cipitria et al., 2011). Electrospun scaffolds can be fabricated using 
biopolymers which include gelatine (GE), collagen (COL), chitosan (CS) and synthetic 
polymers poly (ε-caprolactone) (PCL), poly (lactic acid) (PLA) and polyurethane (PU).  
Electrospun scaffolds can be fabricated using two methods, single and co-axial 
electrospinning which are described in the methods section 4.5 and 4.6.  Kim et al et al., 
2009 stated that fabricating scaffolds using a single solution often produces higher fibre 
density which, leads to the growth of cells being restricted within the scaffold. 
Therefore, to overcome such drawbacks many researchers have explored the 
composite or blending of fibres to create scaffolds. This consisted of combining both bio 
and synthetic polymers. These scaffolds normally do not require a crosslinking agent to 
stabilise the fibres. This is due to their gel-solid like state transition during the hydration 
phase, unlike single or co-axial electrospinning. Single and co-axial spinning usually 
undergoes post treatment with a crosslinking agent like glutaraldehyde (GTA) or plasma 
treatment to stabilise the fibres (Cipitria et al., 2011; Wang et al., 2014). With the 
composite/ blended technique the synthetic polymer plays a vital role in supporting the 
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biopolymer as a nanofibrous backbone whilst the biopolymer acts as a promoter 
supporting the growth and adhesion of cells to the surface of the scaffolds (Kim et al., 
2009). For scaffolds, electrospinning is seen as the most favourable method in 
comparison to other methods like soft lithography, photolithography and bio-plotting 
which all can be costly and time consuming. Whereas electrospinning requires low-cost 
laboratory equipment, is versatile and multiple bio and synthetic polymers are readily 
available for use in research. Furthermore, electrospinning also provides the 
opportunity to control fibre diameter, alignment and reproducibility (Cipitria et al., 
2011).  
In this chapter the development of nanofibrous membranes via electrospinning 
technique using biopolymers GE, COL and synthetic polymer PCL is presented. The 
membrane is part of the central layer of the VOC platform, designed to support the 
growth of vaginal tissue.  GE, COL biopolymers and PCL a synthetic polymer were 
selected to fabricate the membranes due to their biodegradability, biocompatibility and 
mechanical properties. A combination of electrospinning methods was used to identify 
which method and type of membrane would be suitable for the VOC application.  
 
4.1 Requirement for a suitable membrane  
• Act as a scaffold to support the growth of vaginal tissue.  
o GE and COL biopolymers were selected for their biocompatibility and 
biodegradability properties to mimic the ECM to support 3D tissue 
growth.  
o PCL was chosen for its mechanical strength to support GE and COL fibres. 
 
• To have a porous structure to control cell function and formation of new tissues. 
o The porosity of the membrane should facilitate cell seeding, infiltration 
and distribution of nutrients to the cells.  
 
• A biocompatible surface suitable for cell adhesion, differentiation, and 




4.2 Biopolymers  
Biopolymers are natural polymers derived from cells of living organisms. They are 
mostly used in tissue engineering for the purpose of mimicking the ECM of tissue of 
interest. This is due to their biocompatibility, biodegradability, cell specific binding sites 
and fluid retention properties (Ramalingam et al., 2019). However, biopolymers tend to 
have poor mechanical strength, degradability and usually requires crosslinking or 
combined with synthetic polymers to enhance their mechanical properties.  
 Gelatin 
Gelatin (GE) is a protein biopolymer which is derived from partial hydrolysis of collagen. 
Due to its good properties of being biocompatible, biodegradable, cell - specific binding 
sites, non-immunogenic and is commercially available at a low cost, makes this material 
favourable in the use of biomedical research (Zhang et al., 2006; Daelemans et al., 
2018). However, gelatin being a polyelectrolyte, contains rigid chain conformations due 
a high number of hydrogen and ionising groups which makes it difficult to fabricate 
scaffolds via electrospinning (Nuge et al., 2013). It is commonly combined with synthetic 
polymers to form fibrous scaffolds.  Due to its solubility, scaffolds with gelatin often 
require crosslinking chemically or physically to ensure fibre stability.   
 Collagen 
Collagen (COL) is known to the be most abundant fibrous protein in the ECM for various 
connective tissue found in the body of animals and humans. Its plays a major role in 
connective tissue that make up the skin, tendon, cartilage and bone. The main function 
of collagen in the body is to provide structure to the ECM, regulate cell function as well 
as strengthening of the bones. Collagen is generally weak in nature and has poor 
mechanical strength. Therefore, it is commonly crosslinked or blended with a synthetic 
polymer to enhance its mechanical properties without affecting the biological activity. 
Collagen has been widely utilised as a scaffold due to its benefits i.e., high surface to 
area volume ratio, cell adhesion, reasonable diameter and porosity for cell embedment 
and transportation of nutrients and provides mechanical cues to define cellular 
behaviour and formation of tissue (Law et al., 2017a).  
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4.3 Synthetic polymer  
Synthetic polymers, derived from petroleum oil or man-made is commonly used for a 
variety of products ranging from medical devices to household items. They are often 
used in tissue engineering due to their beneficial attributes e.g., good mechanical 
properties, greater flexibility, highly durability and tensile strength. However, they can 
exhibit certain disadvantages for example being hydrophobic, lack cell-specific 
recognition sites and slow degradability, therefore requiring further characterisation to 
improve the surface properties for use in biomedical applications (Ramalingam et al., 
2019).   
 Poly (ε-caprolactone) 
 
Polycaprolactone (PCL) is a hydrophobic semi-crystalline polymer made from ring -
opening polymerisation of epsilon-caprolactone which is commonly derived from 
carbon fossil (Nair et al., 2017). PCL exhibits many benefits for example 
biodegradability, biocompatibility, easy to process and has desirable mechanical 
properties (Ramalingam et al., 2019). Due to these properties, it is often used to make 
surgical implants, sutures, wound dressings and drug delivery application for tissue 
engineering. However, as PCL is hydrophobic it lack cell-specific recognition sites which 
affect cell affinity (Haslauer et al., 2011; Daelemans et al., 2018; Ramalingam et al., 
2019).  PCL  has  a slow degradation rate  of at least 3-4 years in water (Woodruff and 
Hutmacher, 2010)(Guarino et al., 2017) however, it can be controlled by the use of 
enzymes and microorganisms (Nair et al., 2017).  
4.4 Materials and Methods 
Materials used to fabricate the electrospun membranes have been listed below, see 
section 4.4.1. The method used to fabricate the membranes was conducted by 
electrospinning. Each solution preparation and method has also been explained below, 
see section 4.5 - 4.6.1. 
4.4.1 Materials  
Polymers of gelatin Type A (gel strength 300) from porcine skin in powder form, 
Collagen Type 1 from rat tail in solution form, PCL (Mn 80,000), solvents 2,2,2-
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Trifluoroethanol (TFE) purity ≥ 99.0%, Glacial acetic acid (AA) purity ≥ 99.0%, Methanol 
purity ≥ 99.8%, Chloroform purity ≥ 99.5%, glutaraldehyde (GTA) grade I were all 
purchased from Sigma-Aldrich, UK.  All chemicals were used as received. Teflon tubing 
with ID X1.00mm (Sigma-Aldrich, UK) and blunt needles 10G, 21G,22G and23G (RS, UK). 
4.5 Preparation of spinning solutions  
There are three ways of preparing electrospinning solutions depending on the method 
used. Single, composite and co-axial solutions for GE, COL and PCL which can be seen in 
section 4.5.1 - 4.5.3 for further details.  
4.5.1 Single solutions 
To make PCL 10% (w/v) solution, 1g of PCL pellets were dissolved at ratio 3:1 
(chloroform: methanol). PCL was left to dissolve in 7.5 ml chloroform overnight on a 
magnetic stirrer at 300 rpm. Once dissolved, 2.5 ml of methanol was then added to the 
solution and left to mix for 1-2 hours until a honey like solution was produced 
(Spraybase, 2018). 
4.5.2 Composite solution  
Composite PCL (8% w/v)/GE (4% w/v) solution were made by dissolving 0.8g of PCL 
pellets and 0.4g of gelatin powder in TFE separately before combing together into one 
homogenous solution at 50:50 volume ratio and left to stir overnight on a magnetic 
plate at 300 rpm. Before using the composite solution, 100 µl of acetic acid was added 
to the mixture and left to stir at 300 rpm for 1-2 hours to  improve the miscibility of the 
solution before use. (Fu et al., 2014 and Ramalingam et al., 2019). 
4.5.3 Co-axial solution 
For the core-shell fibrous membranes, PCL/GE and PCL/COL solutions were made 
separately. For both membranes PCL (10% w/v) at (75:25) solution was made using the 
single solution method, see section 4.5.1 for the inner core of the fibres. GE (10% w/v.) 
and COL (4% w/v.) were both dissolved in TFE overnight at 300rpm. GE and  COL were 
both  used as the shell of the fibres respectively (Coimbra et al., 2017 and  Burugapalli 




 Crosslinking  
Crosslinking is a chemical reaction that forms covalent bonds or short sequences of 
bonds that join two polymers together. Due to the nature of the biopolymers, gelatin 
and collagen are mechanically weak and soluble in water. Therefore, to improve their 
fibre stability and solubility in water PCL/GE and composite membranes were 
chemically cross-linked with GTA vapour (Burugapalli et al., 2018). Samples were placed 
into a vacuum desiccator for 3 days with 10 ml of 25% aqueous GTA solution. Whereas 
PCL/COL samples were physically cross-linked under UV radiation for 30 mins before 
being used for further experimentation (Coimbra et al., 2017). 
4.6 Electrospinning setup and single method 
The electrospinning setup, manufactured by AC solutions Ltd, UK seen in Figure 4.1 
consists of a syringe pump Fusion 100 (KR Analytic, UK) placed in the horizontal position. 
The electrospun solution is placed into a 10mL syringe (BD, US), where a flow rate is 
applied and controlled by the syringe pump. The syringe is then attached to Teflon 
tubing with an internal diameter of 1.0 mm. Placed at the end of the tubing a long blunt 
needle also known as the spinneret, where the positive electrode is clamped to. 
Depending on the solution being spun, the distance between the needle and collective 
plate can be modified accordingly to produce nanofibers. The negative electrode is 
attached to a metal static plate covered in aluminium foil, non-shiny side up which 
makes it easier to remove as-spun fibre membranes for analysis and further 
experimentation. An adjustable high voltage supply (EL30R1.5, Glassman High Voltage 
Inc., UK) located at the top of the electrospinning unit is used to stimulate an electrical 














The following solution parameters concentration, temperature, humidity, voltage, 
distance and flow rate were applied in reference to protocols for each sample and 
method which can be found in Table 4.1. 
Table 4.1 Parameter settings used for electrospinning nanofiber membranes.
 
4.6.1 Co-axial spinning  
The set up for co-axial spinning involves electrospinning two polymer solutions 
simultaneously to fabricate nanofibrous membranes. This is done by using a T-junction 
spinneret made with two blunt needles sharing an axis which, allows one solution to 
flow through the other creating the inner ‘core’ and outer ‘shell’ arrangement seen in 
Figure 4.1 Electrospinning setup manufactured by AC 

















Figure 4.2 B. This method consists of two pumps placed at the horizontal position fusion 
100 pumps (KR Analytic, UK), with two syringes connected to Teflon tubing. The samples 
were fed through at specific flow. Voltage and the height between the spinneret and 
collective plate were adjusted respectively to ensure stable fibre formation (Figure 4.2 
A). Co-axial electrospinning parameters for both PCL/GEL (Coimbra et al., 2017) and 
PCL/COL (Haslauer et al., 2011) can been seen in Table 4.1. All experiments were carried 
out under ambient temperature and humidity. Membranes were left to crosslink and 









4.6.2 Evaluation of Fibre Diameter and Morphology  
Surface morphology and fibre diameter of the electrospun membranes were observed 
under scanning electron microscopy (SEM) (JEOL JCM-6000, Japan). Prior to SEM, small 
membrane samples were cut into 1 cm x 2 cm rectangles and placed onto stub holders 
with carbon tape to increase conductivity for coating. The samples were sputter coated 
in gold for 2 mins at 1.5 kV (OM-SC7640 Sputter Coater, UK) seen in Figure 4.3. SEM was 




Figure 4.2 (A) Co-axial electrospinning set up; (B) Schematic of co-axial fibres with core (PCL) and shell 
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Figure 4.3 (A) Sputter coater device (OM-SC7640, UK); (B) 1 cm x 2 cm electrospun samples placed onto 
stub holders using carbon tape to sputter coat samples in gold for 2 mins. 
4.6.3 Fibre Diameter Measurement 
SEM images were used to measure the fibre diameter of the membranes. Image J 
software (National Institute of Health, Bethesda, MD, USA) was used to calculate the 
average fibre diameter by randomly selecting and measuring at least 100 fibres per 
sample (n=3) for each membrane (n=4) to determine the average fibre diameter. SPSS 
Statistics (IBM software, USA) was used to analyse the data which were expressed as 
mean ± standard deviation (SD).  
4.6.4 Contact angle measurements  
Contact angle measurements were conducted on the electrospun membranes PCL, 
PCL/GEL, PCL/COL, and composite using the FTA32 a video-based goniometer (FLC, 
USA). The FTA32A and software, drop shape analysis was used to evaluate the 
wettability of each membrane. A syringe with a needle of 30G (ID 0.121 mm and OD 
0.305 mm) was loaded with deionised water was manually moved to dispense a water 
droplet approximately 0.5µL on the membranes seen in Figure 4.4. The software 
captures the droplets shape automatically and calculates the angle between the slope 










Figure 4.4 FTA 32A goniometer instrument use to measure contact angle of membranes (n=4) 
4.6.5 Uniaxial Tensile Measurements 
Tensile strength measurements were conducted on the four (PCL, PCL/GEL, PCL/COL 
and composite) samples to determine the mechanical properties of each membrane. 
This test was preformed using the Tensile Stress Testing Stage (TSTS350, Linkam 
Scientific Instruments, UK) equipped with a 20N load cell. Rectangular-shaped samples 
(3 cm x 1 cm) with an average thickness of 10-70 µm were stretched in the y – axis at a 
constant crosshead speed of 250µm/sec (Figure 4.5). The samples were clamped and 
screwed down at the both ends to prevent samples from sliding during the testing 
(Ramalingam et al., 2019).  
LINK Control software was used to perform the mechanical tests. The thickness, length 
of sample, load cell and velocity parameters were entered into the software to run the 
experiments. Mechanical tests were conducted and repeated three times per sample in 
ambient conditions and ran until sample failure.  Data sets from each membrane were 
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Figure 4.5 TSTS350, (Linkam Scientific Instruments, UK) measuring the tensile strength of an electrospun 
membrane under 20N load cell and pulled in the y-axis direction with a speed of 250µm/sec until sample 
failure. (A) sample at the stationary position; (B) Sample at failure. 
 
4.7 Results  
Below, presents the results of measurements and statistical analysis conducted on each 
membrane. These tests were done to evaluate performance of each membrane and to 
identify which sample would be suitable for the VOC platform.  
4.7.1 Morphology of Membranes 
The following membranes PCL, PCL/GE, PLC/COL and composite were prepared using 
either the single, co-axial or composite methods as described above in section 4.5. SEM 
imaging was conducted on the membranes to observe the morphology of the fibres. 
Frequency percentage is usually measured as general practice to evaluate the average 
fibre diameter which was then analysed in SPSS (IBM Software, US). Figure 4.6 presents 
SEM images of each membrane with their corresponding fibre distributions. As seen in 
Figure 4.6 (A) PCL membrane, (C) PCL/GE membrane and (G) composite membrane the 
nanofibers appeared to be smooth, bead-free and uniformed, whereas in Figure 4.6 (E) 
PCL/COL membrane, displays smooth fibres but lacked uniformity.  
The membrane contained a mixture of large and small nanofibers that varied in 
diameter. In Figure 4.6 (B) PCL membrane had an average fibre diameter of 761.67 
±237.296 nm, PCL/GEL membrane 575.65 ±142.628 nm, PCL/COL membrane 540.55 
±293.09 nm and Composite membrane 257.25 ±72.919 nm. In comparison to PCL/GE 
and PCL/COL membrane, the composite membrane contained smaller nanofibers in 
A B 
Tensile and 
compression grips in 
the y -axis 
Samples size 
(3 cm x 1 cm) 
Force beam 20N 
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diameter due to the difference in concentrations used to make the composite solution. 
Composite membrane was made with a lower concentration of 8% PCL and 4% GEL 
which resulted in thinner fibres.  
For tissues engineering it is desirable for electrospun membranes to have no beads with 
fibre diameters that closely resembles the ECM morphology to stimulate cellular 
growth. The membranes were fabricated to identify a suitable scaffold to support the 
growth of vaginal epithelial cells which are approximately 12-14µm in size. SEM was 
conducted on each membrane to examine the morphology of the fibres. A total of 300 
fibre diameter measurements per membrane (n =4) were observed. Results indicated 
that all membranes exhibited thin, smooth and bead- free fibres, varied in size with a 
mean diameter between 260 nm - 765 nm, fibre diameter range that is suitable to 











PCL 10%(w/v)/GEL 10%(w/v) 
PCL 10%(w/v)/COL 4%(w/v) 
PCL 8%(w/v)/GEL 4%(w/v) 
Figure 4.6. SEM of electrospun membranes (A) PCL membrane (2000x); (C) PCL/GE membrane (2000x); (E) PCL/COL 
membrane (2700x); (G) Composite membrane (4000x) with their respective fibre diameter distributions (B) PCL 
membrane; (D) PCL/GE membrane; (F) PCL/COL membrane and (H) Composite membrane. 
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4.7.2 Stress-strain Curves  
Figure 4.7. Stress -Strain curves on all electrospun membranes (n = 4) 
The role of the fabricated membranes was to provide a scaffold that would mimic the 
ECM to support the growth of vaginal tissue at the centres of the VOC platform. 
However, it is important that the membranes also express similar properties to vaginal 
tissue. In order understand the mechanical properties of the membranes tensile 
strength measurements were conducted to evaluate the stress-strain behaviour in 
comparison to mechanical properties of vaginal tissue. The mechanical properties were 
compared to vaginal tissue from women with prolapse during prolapse repair surgery. 
Baah-Dwomoh et al., 2016 indicated that strain at failure ranging from 19-41% and 
stress at failure ranging from 2.12-6.06 MPa for prolapsed tissue whereas non-
prolapsed tissue indicated strain at failure ranging from 20-46% and stress at failure 
ranging from 0.82-2.62 MPa.   
 
Figure 4.7 expresses the stress-strain behaviour of the four membranes, PCL membrane 
had a strain at failure 65% and stress at rupture 1.4 MPa, PCL/GE membrane had strain 
at failure 8% and stress at rupture 1.7 MPa, PCL/COL membrane had strain at failure 
43% and stress at rupture 1.2 MPa and composite membrane had strain at failure 12 % 
and stress at rupture 1.6 MPa. Figure 4.8 presents the PCL/GEL and composite 
membranes stress- strain relationship more closely. The young’s modulus was also 
calculated and determined for the four membranes, (PCL) 25.8 kPa, (PCL/GE) 0.60 MPa, 






















of the material which, is defined by the relationship between stress and strain of a 
material. The results of the fabricated membranes indicated a variation in stiffness 
which expressed the composite membrane to show similarities of stress and strain 
values of non-prolapsed tissue, making it most suitable membranes for the VOC 
application. Due to the limitation of data available on the mechanical properties of 
healthy vaginal tissue the membranes were compared to tissue undergoing prolapsed 
repair surgery.  For further statistical analysis, mechanical properties from at least 10 
healthy vaginal epithelial tissue are required. The data could then be used to examine 
variance between healthy tissue and electrospun membranes, providing the target 
values as guidance to identify the mechanical properties required to fabricate a suitable 
membrane for the VOC platform.  
 





















4.7.3 Contact Angle 
Contact angle (CA) measurements were conducted on all four membranes to identify 
the membranes wettability surface properties. CA measurement measures the angle 
between the solid surface and the water droplet dispensed onto the surface. The angle 
indicates whether the surface is hydrophobic or hydrophilic (Figure 4.9). The 
membranes have been experienced mechanical testing and fibre morphology 
observations to identify the best membrane for VOC platform. Therefore, it is essential 
that CA measurements is also considered has this parameter can have effect on cell 
attachment, migration and proliferation and the movement of the fluid flow in the 











Figure 4.9 Contact angle measurement table presenting the angles for spreading to no wetting which 
informs whether a surface is hydrophobic of hydrophilic (Solving the Problems of Plastics Adhesion | 
Adhesion Bonding, 2012).   
The results in Figure 4.10 demonstrates the contact angle for PCL, PLC/GEL, PLC/COL 
and composite electrospun membranes (n = 4) at 0 seconds and 5 seconds which was 
repeated three times to refine the experiment observation for each membrane. From 
the results it was expected that PCL membrane would have a high CA as it is a polymer 
known to be hydrophobic gave a CA value of 121.54°. From 0 seconds to 5 seconds the 
angle did not change. In relation to the Figure 4.9 the angle is between 90°-180°, the 
water droplet indicated incomplete wetting the PCL surface. If PCL was selected as the 
membrane for VOC platform, the wettability properties must be altered to make the 
surface more hydrophilic for cell retention. To improve cell specific binding site, PCL can 
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be coated with collagen, fibrin or Arginylglycylaspartic acid (RGD) a peptide that can 
simulate cell adhesion to the ECM.  
 
Figure 4.10 Water contact angle of PCL, PCL/GEL, PCL/COL and Composite membranes at 0 seconds and 
5 seconds (n=4). 
PCL/GE membrane had a CA of 77.97° at 0 seconds which decreased after 5 seconds to 
40.70° indicating the surface had a good wettability angle from the beginning which 
gradually decreased over time. PCL/GEL membrane was electrospun via the co-axial 
method with the fibres in shell-core formation. Gelatin in known to be hydrophilic and 
is commonly used for biomedical applications like wound dressings and tissue 
engineering scaffolds. This is because it of its good biocompatibility and cell adhesion 
properties. It was noted that the CA angle changed as the water wicked through the 
porous membrane. PCL/COL membrane had a CA of 124.44° at 0 seconds which at first 
exhibited an incomplete wetting angle but decreased to 20.2° after 5 seconds indicating 
the surface expressed good wettability. However, having a larger angle at the beginning 
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may cause issues during loading of sample to the surface of the membrane, which could 
lead to lack of cell adhesion.  It would be ideal for the contact angle to be below 90° to 
improved cell adhesion and migration. The composite membrane expressed similar 
wettability properties to PLC/GE with a CA of 61.78° at 0 seconds which then decreased 
to 29.66 ° after 5 seconds, indicating the surface had a good wettability angle overall.  
Both the composite and PCL/GE membrane expressed good wettability, signifying they 
both could be ideal choice of membranes for culturing the vaginal cells.  
4.8 Electrostatics Forces 
Electrostatic force is a phenomenon where the properties of stationary or slow-moving 
electric charges are involved. This phenomenon arises from the forces that electric 
charges exert on each other and are described by Coulomb’s law. The force can be 
attractive or repulsive and its strength can be easily higher than that of the van der 
Waals forces.  The forces have been taken into consideration to understand the 
involvement electrostatic forces impact on cell adhesion which is curial for the VOC 
platform as the model contains an electrospun membrane to support the growth of 
vaginal tissue.  
Van der Waals force is a term used to define the attraction of intermolecular forces 
between molecules. There are two types, London Dispersion Force and dipole-dipole 
forces. LDF is the weakest intermolecular force, it temporarily creates dipole forces 
when two adjacent atoms come into position. Whereas dipole-dipole force is similar to 
LDF but occurs in molecules that are permanently polar, meaning when polar molecular 
being positive attracts the negative pole of another molecular creating the dipole-dipole 
force. 
Capillary force is the ability of a liquid that flows through narrow space without the need 
of external forces such gravity; this is due to two opposing forces; cohesion and 
adhesion. Cohesion is when there are attractive forces between similar molecular or 
atoms that can bond with neighbouring molecules. Whereas adhesion is the attractive 
force that happens between different molecules and atoms, for example molecule of 
cells adhering to the molecule of the polymers based in the electrospun membrane. 
Capillary force of a liquid is usually higher when adhesion force is greater than cohesion 
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force but when cohesion force is higher than adhesion force the capillary force is lower. 
Darcy law equation is considered for the VOC device, the law describes the flow of a 
fluid through a porous medium, the pressure in the y- direction is higher than that in 
the x-direction. The change in pressure is negative therefore the flow will be in the 
positive x-direction. 
Cells are normally negative in charge, to ensure the cells adhere to the surface of a 
biopolymer/synthetic polymer the surface must be characterised. There are two ways 
to distinguish the surface charge of electrospun fibre mesh or other types of material 
being used as a scaffold 1) to measure the resistance across the membrane using the 2 
/ 4-point probe and by using the conductivity equation determine the resistance. 2) 
Working in reserve by using FTIR spectroscopy, an analytical technique used to identify 
organic, polymeric and inorganic material. The FTIR analysis uses infrared light to scan 
samples and determine the chemical properties. The chemical properties provide 
information of the chemical structure of the material for example the side chains which 
determines the surface charge of the material.  
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In general, electrostatic interactions are repulsive because both cell and particle 
surfaces are negatively charged. In contrast, hydrophilic interactions and van der Waals 
forces tend to be attractive. Initial adhesion occurs when attractive forces overcome 
repulsive forces. Porous medium properties in conjunction with cell surface properties 
determine the relative importance of each of these interactions. Table 4.2 illustrates 
how the interaction of electrostatic and van der Waals forces governs reversible 
adhesion at various distances between the cell and particle surfaces. When a cell 
surface is in actual contact with, or very close to, a particle surface, the attractive forces 
are very strong, creating a primary minimum.  
The forces governing the primary minimum are short-range forces which include 
hydrogen bonding and ion pair formation. As the two surfaces are separated slightly 
e.g., by several nanometres, repulsive forces grow quickly and prohibit adhesion. At 
slightly longer distances, another shallower minimum exists called the secondary 
minimum. It is the secondary minimum that is responsible for the initial reversible 
adhesion of microbes. The figures in Table 4.2 show the cell and particle surfaces are 
not in actual contact at the secondary minimum. As a result, cells can be removed from 
the surface easily, for example, by increasing the water flow velocity or by changing the 
chemistry of the porous medium solution, e.g., ionic strength.  
4.9 Summary  
This chapter introduced the electrospinning technique and how biopolymers GE and 
COL and synthetic polymer PCL were used to fabricate the membranes for the centre 
layer of the VOC model. Observation of fibre morphology and fibre diameter indicated 
all four membranes contained smooth, bead-free nanofibers suitable for the VOC 
application. Tensile strength measurements of the membranes compared to vaginal 
tissue of prolapsed women undergoing prolapse repair surgery indicated the composite 
membraned to be closely related to the mechanical properties of non-prolapsed vaginal 
tissue and ideal for the VOC platform. Finally, contact angle was conducted to examine 
the wettability properties of each membrane. Results suggested that PCL/GEL, PCL/COL 
and composite membranes were the suitable scaffolds due to their CA angles being 
below 90°, exhibiting good wettability, ideal for wicking cells across the membrane and 
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supporting the growth of vaginal tissue. From the experiments conducted on the 
membranes it is clear that the PCL/GE and composite membrane seem more favourable 
choice of membranes for the VOC platform. To classify the choice of membrane, the 
membranes must be subjected to further experimentation i.e., biocompatibility and 




Chapter 5 – Assessment of VOC membrane 
biocompatibility using VK2/E6E7 (vaginal epithelial 
cells)  
 
To accomplish the central layer of the VOC, membranes were created using the 
electrospinning techniques and underwent mechanical testing, contact angle and Image 
analysis to identify which membrane would be ideal for the use of supporting vaginal 
tissue growth. Four membranes were fabricated using biopolymers GE and COL and 
synthetic polymer PCL. These materials were chosen for their biodegradability and 
biocompatibility but to ensure these were suitable for the VOC platform, cell culture 
and cell viability experiments were conducted on the membranes. Immortal cell line 
VK2/E6E7 vaginal epithelial cells was kindly provided by from Dr Fichorova (Brigham & 
Women’s Hospital, Department of Obstetrics and Gynaecology, Laboratory of Genital 
Tract Biology) and was used for the experiments conducted in this chapter. The cell line 
is also available from the ATCC website, categorised under ATCC CRL-2616. 
5.1 Materials  
Materials used for all the cell culture procedures and cell viability tests and fluorescence 
imaging have been listed below in further detail.  
5.1.1 Cell line 
Vaginal epithelial cells VK2/E6E7 was originally derived from the vaginal mucosal tissue 
from a 32-year-old patient who had endometriosis in 1996. Tissue samples were 
collected during anterior-posterior vaginal repair surgery. The cell line was created in 
1997 which contained normal vaginal epithelial cells, immortalized through infection of 
human papillomavirus (HPV) type 16 (Fichorova  et al., 1997). 
5.1.2 Growth Media for VK2/E6E7 
The following ingredients were required for the growth media of VK2/E6E7cell line: 
Keratinocyte serum free medium (SFM) 1X, 500mL, which contains L- Glutamine and a 
phenol red indicator. Additional supplements, epidermal growth factor (EGF 0.5mL, 
final concentration 0.1ng/mL) and bovine pituitary extract (1 vial BPE 2.5mL, final 
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concentration 50µg/mL) were provided separately. Penicillin-streptomycin (P/S 100X, 
5ml with a final concentration of 100 units/mL) all components were purchased from 
Gibco Thermo Fisher, UK. Calcium chloride (CaCl2) (22.05mg with a final concentration 
of 0.4mM) was purchased from Sigma Aldrich, UK.  
To make the correct composition of growth media for VK2/E6E7 cells, the following 
ingredients presented in table 5.1 were added to the 500mL of SFM 1X. 
Table 5.1. Ingredients for VK2/E6E7 Keratinocyte serum free medium. 
Ingredients Volume 
EGF – 0.0324ng/ul 1.54mL 
BPE – 25mg 2.5mL (1 Vial) 
CaCl2, – 22.05mg with a final concentration of 0.4mM 500µl 
Penicillin-Streptomycin (P/S) 100 units/mL 2mL* 
* 2mL of (P/S) was only used for the first time when culturing the cells for stock keeping. To 
maintain the cells media without P/S was used, this was done for the purpose of using the cells 
for experiments with bacterial.   
Two vials of VK2/E6E7 cells with passage numbers P37 and P42 were provided by Dr 
Fichorova. P37 was stored immediately for future use due to the low passage number 
with respect to the passage numbers provided. Though both passage numbers were 
high, this was taken into consideration to monitor and evaluate the performance of the 
cells especially during experiments as cells with high passage numbers tend to 
experience changes in morphology, growth rates and protein expression.  
After preparing the media, vial P42 was taken out of the dry ice and left to thaw at room 
temperature in preparation for cell culturing. To ensure cells were proliferating well, 
two types of media were created, one with P/S and one without. Cells were first grown 
with media containing P/S to achieve sterile and optimal growth to freeze cells for stock. 
P/S is commonly used in cell culture protocols to maintain sterilisation, inhibit bacteria 
growth and to prevent contamination. However, a vial of cells was taken and 
continuously grown in media without P/S to achieve cell culture. This was done to 
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ensure cells were able to grow without the need for antibiotics and to conduct 
experiments with bacterial species i.e., Lactobacillus Crispatus.   
5.1.3 Growth Media for Resuspending 
Gibco DMEM/F12 (Dulbecco's Modified Eagle Medium/Nutrient Mixture F-12) – widely 
used basal medium used for growing many different mammalian cells. The medium was 
supplemented with 10% of Horse serum. Both were purchased from Gibco, Thermo 
Fisher, UK.  
5.1.4 Trypsin – EDTA (0.05%), phenol red 
Gibco Trypsin-EDTA is a proteolytic enzyme mixture derived from porcine which is used 
to dissociate adherent cells from the surface of the flask they are cultured in. The trypsin 
breaks down the protein that allows cells to adhere to the surface. It is commonly used 
for cell dissociating and routine cell culture passaging.  
5.2 Methodology  
The following methods presented below in section 5.2.1 -5.2.7.1 were carried out to 
conduct the cell culture, cell viability and fluorescent imaging experiments.  
5.2.1 Thawing and culturing of VK2/E6E7 cells 
Cells are taken out of liquid nitrogen or dry ice and placed on ice. They are then 
transferred onto a water bath at 37°C until completely thawed (inverting occasionally). 
Once thawed, 1 ml of cell suspension was then transferred into a 15 ml centrifuge tube 
(Thermo fisher, UK). 9 mL of DMEM/F12 media supplemented with 5% Horse serum 
was added drop wise to the cell suspension. This step was done slowly to avoid media 
and cells mixing.  A total of 10 ml cell suspension was then centrifuged for 5 mins at 
1000 rpm to remove freezing media of which the cells were stored in, when in liquid 
nitrogen. The cell supernatant was then removed, leaving the pellet of cells, which is 
then carefully resuspended in 1 ml of pre-warmed (37°C) SFM media. 9 ml of fresh pre-
warmed (37°C) SFM media was then added to a T75 flask (Thermo Fisher, UK) and to 
this, 1 ml of cell suspension was transferred. Cell culture procedures are always 
conducted under the laminar flow cabinet to prevent contamination. The flask is then 
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gently moved in a north to south, east to west movement for the cells to spread evenly 
across the flask. The cells are then checked under a light microscope to ensure they are 
in single cell suspension and not in clumps. The flask is sprayed with 70% ethanol and 
placed into the incubator at 37°C with 5% CO2 for 48 hours for cells to start proliferating 
in optimal conditions.  
5.2.2 Maintaining cells 
Media is changed every 2-3 days depending on the colour of the media. For T75 flask 
10ml -15 ml of media can be fed to the cells; for T25 flask 5-7 ml of media. SFM is light 
pink in colour and as cells start to proliferate and absorb nutrients from the media a 
change in colour can be noticed. If media is left unchanged for longer than 3 days, the 
media will start to appear orange/yellow in colour, this is due to metabolites being 
released by the cells which causes the media to become more acidic, resulting in a lower 
pH.  Therefore, cells must always be monitored and handled carefully to avoid 
contamination and human error.  
5.2.3 Health of a cell line  
To maintain a healthy cell line, the growth of the cells is maintained by evaluating the 
standard growth curve. Growth curves are used to understand the growth characteristic 
patterns of cell lines. After seeding the cells, the cells enter the lag phase where cells 
grow slowly as they begin to adapt to their environment. This is then followed by an 
exponential growth called the log phase (Figure 5.1). During this phase, cells begin to 
consume all the nutrients in the growth media and expanded with no room left to 
develop further. It is at this stage the cells should then be sub-cultured or harvested to 
maintain optimal cell density for future experiments, where cells would stimulate and 
proliferate further. When cells have exceeded the capacity of its growth media, the cells 
then enter the stationary phase where proliferation is significantly reduced or 
terminates completely. Passaging at varying cell densities provides the opportunity to 
monitor cell behaviour and to achieve the optimal growth and yield appropriate for the 
cell line of interest. To ensure optimal growth, cells must be monitored. Changes in 
media (colour and pH), turbidity, contamination or environmental factors i.e., changes 
in temperature or gas can indicate the culture is unhealthy. This can be seen at 
89 
 
macroscopic level by eye, but further examination can then be performed using an 
inverted light microscope to check cell morphology and growth patterns. It is important 
to understand the cell line and maintain a cell culture protocol to make sure cells are 






5.2.4 Subculture cells  
It is important that cell lines are passaged and harvested before cells reach confluence, 
this is to ensure cells maintain their phenotype and culture quality. If cells are left to 
reach confluency, they take longer to recover. VK2/E6E7 cells were harvested at 
approximately 60% in confluence. If experiments required a large seeding density, cells 
are then sub-cultured into different dilution factors of 1:10 and 1:5. Experiments should 
be completed within 10 passages as cell lines will start to changes in morphology, 
growth rate, protein expression and response rate compared to lower passaged cells.  
To subculture VK2/E6E7 cells, cells are observed under a light microscope to confirm 
cells had reached a confluence level of approximately 60%. Once confirmed, media was 
then removed from the flask and briefly rinsed with 5 mL of (pre-warmed at 37°C) 
Trypsin – EDTA (0.05%) for a T75 or 3 mL for a T25. The Trypsin – EDTA (0.05%) was 
Figure 5.1 Growth curve presenting the four phases’ cells go through during cell 
culture. Lag phase, cells grow slowly adapting to their environment. The log phase is 
where cells experience exponential growth by consuming the nutrients from the 
growth media. At the stationary phase cell growth begins to reduced significantly  
leading to the death phase where cells die,  caused by lack of nutrients and 
inhabitable conditions (Straube and Müller, 2016). 
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immediately removed and replaced with 5mL Trypsin – EDTA (0.05%) for a T75 or 2 mL 
for a T25. Flasks were then sprayed with 70% ethanol and placed into the incubator at 
37°C for about 10 mins for cells to detach from the surface of the flasks. Detachment of 
cells were then checked under the light microscope.  
To terminate the trypsinisation, 10 ml of neutralisation buffer (pre-warmed DMEM/F12 
media with 5% horse serum) was added to the cells for a T75 or 5 ml for a T25. During 
this step, neutralisation buffer was pipetted up and down a few times to capture all cells 
on the surface on the flask. 13 ml of cell suspension from a T75 or 7ml from a T25 flask 
was then transferred into a 15 mL centrifuge tube and centrifuged for 5 mins at 1000 
rpm. The cell supernatant was then removed, and the remaining pellet was 
resuspended with pre-warmed (37°C) SFM media depending on the dilution factor 
required. Cells are then distributed accordingly into flasks with fresh pre-warmed (37°C) 
SFM media. Cells are then checked again under the light microscope for single cell 
suspension before being placed into the incubator at 37°C with 5% CO2.  
5.2.5 Cell counting  
Cell counting is important, to identify the cell density in a flask for either freezing cells 
or for experiments. Cell are counted and diluted, respectively. During the sub-culture 
process 1 ml of suspension is taken aside for counting. A plastic disposable 
haemocytometer was used for counting cells manually. Approximately 10-20 µl of cell 
suspension is pipetted onto two chambers that contain a grid of 10 large square that 
measures 1 x 1 mm, each square contained a smaller grid of squares 4x4 (16 cells). The 
haemocytometer is then placed onto a light microscope and cells are manually counted. 
All 10 squares were calculated for both chambers and averaged. Once the total number 
of cells have been calculated the cell concentration can then be determined by using 
the following equation (1). Usually a T75 flask with VK2/E6E7 cells has a total cell 
concentration of ~3million cells. For T25 has a total cell concentration of about 1.5-2 
million cells.  
Limited studies have worked with VK2 E6/E7 cell line but according to the following 
studies by Fichorova et al., 1997;  and  Saha et al., 2017 the cell line maintained a stable 
phenotype after passaging continuously for more than a year. Whereas, Radwan-
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Pragłowska et al., 2020 conducted their experiemnts with cells at passage 1 and 5.The 
cells took over a week to reach 60% in confluence but this may be due to the high 
passage number which influence the growth rate. A grow curve was not conducted but 
would have been helpful to evaluate the health of the cell line before experimenting. 
This would be beneficial for future work with the cell line.  
(𝟏) 𝑻𝒐𝒕𝒂𝒍 𝒏𝒐. 𝒐𝒇 𝒄𝒆𝒍𝒍𝒔/𝒎𝒍 
𝑻𝒐𝒕𝒂𝒍 𝒏𝒖𝒎𝒃𝒆𝒓 𝒐𝒇 𝒄𝒆𝒍𝒍𝒔 𝒄𝒐𝒖𝒏𝒕𝒆𝒅 
𝒏𝒐. 𝒐𝒇 𝟒𝒙𝟒 𝒔𝒒𝒖𝒂𝒓𝒆𝒔 
× (𝑫𝒊𝒍𝒖𝒕𝒊𝒐𝒏 𝒇𝒂𝒄𝒕𝒐𝒓)
× 𝟏𝟎𝟎𝟎𝟎 𝒄𝒆𝒍𝒍𝒔/𝒎𝒍 
5.2.6 Cryopreservation of cells 
To stock the cell line for future experiments cells were frozen at their earliest passage 
number in respect to the passage number provided. When cells have reached a 
confluence level of about 60-70% they are then ready to be frozen. First, freezing media 
is made using the following the procedure in table 5.2. The freezing media was made to 
a total volume of 20 ml. 
Table 5.2. Components required freezing media 
 
Components Volume 
70% DMEM 14ml 
10% DMSO (Dimethyl sulfoxide) 2ml 
20% serum (if using DMEM complete media it already contains 
5% serum therefore only need 15% of serum) 
3ml 
DMSO is added to the media before adding the serum to the mixture. All components 
were thoroughly mixed well and stored at 4°C until further use. A Mr frosty container 
with isopropanol (IPA) was left to refrigerate at 4°C until use. Cells to be frozen go 
through the subculture process of being trypsinised, neutralised and centrifuged to 
obtain the pellet. Just before centrifuging an aliquot of cell suspension was used to 
calculate the cell concentration for each vial to contain 1 million cells.    
Once centrifuged the supernatant is removed and an appropriate volume of freezing 
media is added to the pellet. Cells are gently resuspended with 1 ml of freezing media 
and transferred to the 1.2 ml cryovials (Alpha Laboratories, UK); special vials used for 
cryopreservation. The vials are then labelled with the cell line name, passage number 
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before trypsinisation, date and initials. The vials are then placed into the Mr frosty and 
refrigerated at - 80°C. This allows the vials to freeze at a rate of 1° C/min. The vials are 
left for overnight at - 80°C before being transferred to liquid nitrogen.  


















Figure 5.2 presents the VK2/E6E7 cells progression of proliferating over 8 days. On day 
3 cells were observed at approximately 15%, by day 8 it had reached about 60% in 
confluence. From examining the cells morphology under the light microscope, cells 
begin to form small colonies after 3 days in incubation and the proliferate into large 
















































a start formation, die and shone brightly but was always surrounded by live cells. This 
can be seen in Figure 5.2 at day 8 which is particular behaviour of this cell line which 
has not been seen in other epithelial cell lines.  
Cells were continuously observed and maintain carefully to avoid contamination 
resulting from human error or ambient environment. Culturing procedures were always 
conducted under the laminar flow cabinet. All equipment were sprayed with 70% 
ethanol before use to prevent contamination. When contamination occurred cell 
culture experiments were terminated. The incubator and flow cabinet used were deep 
cleaned with 1% of distal solution to clean infected areas and then sprayed with 70% 
ethanol. Cell culture was carefully planned to guarantee cells would be ready in time of 
experiments i.e., biocompatibility and cell viability tests using MTT assays on 
membranes, bacterial work, and fluorescent imaging on the electrospun membranes. 
5.3 Cell viability test (MTT) – Electrospun membranes (24 well plate) 
The materials selected to make the electrospun membranes were specifically chosen 
due to their mechanical, biodegradable and biocompatible properties. As mentioned in 
chapter 4 both GE and COL, biopolymers will provide anchoring properties for cells 
adhesion to occur at the surface of the membranes.  Synthetic polymer PCL was used 
to provide the mechanical strength to the nanofibers to support the growth of vaginal 
tissue. After successfully growing the vaginal cells in T75/T25 flasks the next step was 
to culture cells onto the electrospun membranes to test for biocompatibility. This was 
done to identify the potential scaffold that would be implemented in the VOC system.  
MMT assay is a colourmetric assay that is used to measure the cell proliferation through 
cellular metabolic activity. A yellow dye, MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (Tetrazole) was applied to the cells which passed into the 
mitochondria where it is reduced by mitochondria reductase enzyme into purple 
insoluble formazan crystals. These crystals can only be found in the mitochondria of 
living cells (Riss. T.L, et al 2004). It is a simple method that provides visual and 




Figure 5.3 The yellow dye (MMT) is reduced by the mitochondrial reductase enzyme which forms 
insoluble formazan crystals (Riss. T.L, et al 2004). 
MTT protocol was carried out in 24 well plates with the following four membranes PCL 
GEL/PCL, COL/PCL and (GE/PCL) composite. First, cells were left to culture to achieve a 
cell seeding density of 20,000 cells/ml. Membranes were then cut into 1.5 cm discs with 
a circular puncher to fit into wells of the 24 well plates. To prevent contamination, 
membranes were sterilised through a series of washes with phosphate buffer solution 
(PBS) pH 7.4 and a serial dilution of ethanol. Membranes were left to dry at room 
temperature and placed under ultraviolet (UV) for 30mins. Samples were then stored 
in PBS solution until ready for use. Once cells and membranes were ready the initial 
steps to run the MTT assay experiments were conducted. Experiments were arranged 
to capture 3 time points (days) and membranes were replicated 3 times to obtain 
independent data from each experiment and to ensure the reliability of the results and 
to identify any patterns in the data. The results were then pooled and normalised to 
perform statistical analysis.  
5.3.1 Set up of experiment  
Cells were cultured and prepared to a seeding density of 25,000 cells/ml. The 
membranes were carefully transferred from the stored PBS into the wells of the 24 well 
plate using tweezers (Thermo Fisher, UK). This was an extremely difficult procedure as 
membranes begin to shrivel when taken out of PBS. To aid the transfer, 1ml of PBS 
solution was placed into wells. Tweezers are then used to open out the membrane as it 
floated on the surface. PBS is then carefully removed from the well, which allowed the 
membranes to sit at the bottom of the well. Due to the lightweight of the membranes, 
nitrile rubber O-rings (Ascot City, UK) with OD 14mm X ID 2 mm were placed on top of 
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the membranes to prevent them from floating during the experiment. A 168 hrs, 72 hrs 
and 24 hrs were the set time points for data collection.  Each column contained two 
membranes as replicates and two controls for that data point. VK2/E6E7 cells were first 
seeded on the first column of wells which represented 168hrs, the second column 
72hrs, third column 24 hrs with the fourth column set as the control (well with cells 
only).  
 
Figure 5.4 24 well plate with membranes held down in the well with nitrile 0-rings to prevent samples 
from floating during experiments. 
Cells were monitored and media was changed when necessary. The experiment lasted 
a week and on the final day of the experiment the MTT assay was performed. Cultured 
media was carefully removed from the well without disrupting the membrane and cells. 
Then to the well, 500 µl of MMT solution (1/20 dilution added to DMEM media) was 
added to the membranes and left to incubate at 37°C for about an hour until crystals 
were formed. When crystal could be seen, the MTT solution was then removed from 
membranes and control samples. This was followed by a wash step of 500 µl of HBSS 
(Hank’s solution, Gibco Thermo Fisher, UK). Once all HBSS solution was removed from 
the wells 500 µl of DMSO was added to the samples to dissolve the formazan crystals. 
The plates were then left on the shaker for 30mins and covered with aluminium foil due 
to DMSO being light sensitive. After shaking, the crystals dissolved producing a purple 
solution. The darker the solution to more viable cells is present in the sample. 20 µl of 
each sample is then transferred into a 96 well plate, labelled and placed on a 
spectrophotometer to read the absorbance at 570 nm and 620 nm. Then optical density 
 168 hrs      72 hrs      24 hrs   Controls  
1   
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data of the samples were collected and then compared to the controls to identify the 
biocompatibility of the membrane.  
5.4 Statistical Analysis 
The MTT experiments were repeated three times for each membrane. Each membrane 
had two replicate samples each (n = 4).  MTT assay was conducted three times at 
different data points, 24hrs, 72hrs and 168hrs to investigate significance of vial cells 
between the different time points on the different membranes. Experimental data was 
presented as ± standard deviation (SD). ANOVA test was conducted to compare the 
difference between two groups in this case between the membranes for statistical 
comparison. The difference between the mean values of each group were evaluated by 
using a two-sample t-Test assuming equal variance in which p - value less than 0.05 was 
considered significant. The two-sample t-Test was conducted in Excel, where the data 
from each membrane for 24hrs, 72hrs, 168hrs and controls   of each independent test 
were pooled together and normalised. The difference means from each membrane 
were compared with each other and against the control to identify which membrane 
was the most biocompatible in terms of cell viability.    
5.5 Results and discussion  
Results and discussion of the biocompatibility tests, fluorescence and SEM imaging 
preformed on the electrospun membranes have been discussed below.  
5.5.1 MTT results conducted on Electrospun membranes 
The following results depicted in Figure 5.5 -5.7 represents the data obtained from the 
MTT assay experiments. The MTT assay was conducted to measure the number of viable 
cells that remained attached to the membranes after incubation period. This was then 
compared to the control. The experiment was carried out on following membranes PCL, 
PCL/GE, PCL/COL and composite to investigate the compatibility of membranes in order 
to identify a suitable membrane for the VOC system. The cells were incubated with the 
membranes for three time points: 24 hrs, 72hrs and 168hrs. These time points were 
selected to ensure cells would have enough time to adhere to the membrane and 
replicated for data collection. Controls were cultured on the 24 well plates at the same 
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time points but without a membrane to act as the standard reference. The data 
presented results from three independent experiments conducted on each membrane. 
A two-sample t-Test assuming equal variance in which, p-value < 0.05 was considered 























    






























































































Figure 5.7. Represents all membranes cell viability in relation to the control (P <0.05) after 168 hrs (n=4) 
The data presented in Figures 5.5, 5.6 and 5.7 indicated PCL/GEL, PCL/COL and 
composite membranes were biocompatible to support VK2/E6E7 cells. Each membrane 
expressed the expected growth pattern in relation to cell viability at different time 
points in relation to the control. After 24hr a significant difference can be seen between 
the membranes and control. This is due normal characteristic of cell growth after 
seeding cells enter the lag phase in which they begin to adapt to their environment 
before proliferating. A low seeding cell density of 25x10³/mL was applied to each 
membrane but due to the low density may not have been a sufficient sample. Cells also 
were exposed to new material, the membrane which may needed longer for the cells 
to adapt and adhere to the surfaces of the membranes.   
The VK2/E6E7 cells under normal cell culture procedure took roughly 48-72 hrs to 
express signs of proliferation, this may be due to the high passage cell sample which 
may have influenced the cell growth.  At 72 hrs a decrease in cell number was observed. 
The cell viability compared to the controls showed that there were fewer cells at 72 
hours in comparison to cells at 24 hours. This was observed in all the membranes, 
suggesting the cell required more time to proliferate, adhere and adapt to their 
surroundings or died due insufficient conditions. MTT assay only considers the 
mitochondria of living cells attached to the membrane and floating. The cell absorbance 















































In Figure 5.5 -5.7 PCL membrane showed clear significance of viable cells with the 
control and between the composite membrane at 24 hrs, 72 hrs and 168 hrs. There was 
a minimal change in cell growth at these time points. This is due to PCL being a 
hydrophobic synthetic polymer. Though it is known for its good mechanical properties, 
it lacks cell recognition sites to exhibit cell adhesion. PCL expresses a contact angle of 
>90° which represents incomplete wettability, cells applied to the scaffold floated on 
the surface of the membrane rather than wick through the nanofibers, inhibiting and 
reducing cell adhesion. PCL samples used in this experiment had a contact angle of 
121.54° seen Figure 4.10 in chapter 4 was not treated to improve cell adhesion. To 
improve cell attachment to PCL membranes can be further functionalised  by adding 
RDGs to enhance integrin bonding and focal adhesion (Bellis, 2011; Khalili and Ahmad, 
2015).  At 168 hrs, a decrease in proliferation can been seen for PCL membranes at 0.29-
fold change indicating that PCL membrane alone is not suitable for the VOC platform 
without further treatment.  
Both the co-axial scaffolds PCL/GE and PCL/COL seen in Figures 5.6 and 5.7 have shown 
an increase in cell number from 72 hrs to 168 hrs, indicating cell number increased on 
the PCL/GE membrane due to proliferation from 54% to 100% whereas, PCL/COL only 
had a minimal increase from 44% to 48% in relation to the control. Both the co-axial 
membranes contained biopolymers of GE and COL and it is expected that cell 
proliferation would be higher in both membranes as they have good fluid retention, 
porosity and cell specific binding sites (Ramalingam et al., 2019). However, PCL/GE 
scaffold performed better in terms of cell absorbance than PCL/COL which indicates 
that PCL/COL membrane may not a suitable membrane for maintaining cells longer than 
a month. This may be due fabrication process of the membrane and the diameter of the 
fibres. Though the membrane was crosslinked to stabilise the fibres of collagen, cross-
linking treatment can reduce the antigenicity and immunogenicity (Chen et al., 2019). 
Both the co-axial membranes were crossed linked with glutaraldehyde solution (GTA) 
to stabilise the fibres of gelatin and collagen as they exhibit poor mechanical strength 
and degradability (Ramalingam et al., 2019).  The co-axial method was used to fabricate 
both membranes with gelatin and collagen as the shell and PCL as the core. This 
technique allows the less spinnable polymers with low solubility and molecular weight; 
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gelatin and collagen to form fibres as the shell with the support of a spinnable polymer,  
PCL to provide the desirable mechanical properties at the core (Law et al., 2017b). 
However, collagen structure is known to be unstable and may have denatured causing 
the number of cells to decrease and resulting in lack of proliferation on the membrane.  
Composite membrane PCL/GE (50:50), a membrane fabricated by blending GE and PCL 
into one homogeneous solution and spun using the single method (Zhang et al., 2005; 
Nuge et al., 2013; Lim et al.,  2015; Ramalingam et al., 2019). Within 24 hrs seen in 
Figure 5.5 a clear significance can be seen between the control and composite 
membrane. More viable cells were present on the composite membrane compared to 
the control indicating the cells to had adapted well to the composite membrane. At 72 
hrs though a decrease in cell number was observed in all membranes in relation to the 
control, composite membrane remained significantly higher in cell viability at 100%. 
However, between 72 -1 68 hrs cell number accelerated, possibly due to the hydrophilic 
surface of the composite fibres enhancing fluid retention and increasing cell adhesion. 
As the composite membrane contains GE, cells specific binding sites could also be 
promoting cell adhesion properties and therefore increasing the cell absorbance.  The 
process of cell adhesion is characterised by three stages. Phase 1 is the initial 
attachment which involve electrostatic interaction, creating specific integrin bonds 
between the cells and membranes. 
During phase 2 cells begin to flatten and spread across the membrane decreasing in 
height and attaching to the membrane. At phase 3 cells are structurally organised and 
spread across the membrane this is known as focal adhesion (Khalili and Ahmad, 2015). 
In the study by  (Lim et al.,2015) which examined In vitro biological evaluation of 
electrospun polycaprolactone/gelatine nanofibrous scaffold for tissue engineering the 
PCL/GE composite membrane expressed a higher cell count than the control suggesting 
it to be a suitable scaffold for tissue engineering as it combines the merits of natural 
and synthetic polymers making the membrane biocompatible, hydrophilic and with 
good mechanical properties (Fu et al., 2014) to support the growth tissue. This was 
clearly shown in Figure 5.5-5.7 that compared to the other membranes, the composite 
membrane preformed the best in terms of the number of viable cells compared to the 
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control, informing that the composite membrane is the most fitted membrane to use 
for the VOC platform.  
To conclude, four membranes tested for biocompatibility to grow the VK2/E6E7 cells, 
but PCL/GE, PCL/COL and composite (PCL/GE) membranes were identified as potential 
membranes suitable for the VOC model. Overall, PCL/GE and composite membrane 
produced higher cell viability than PCL/COL and PCL membranes and therefore 
considered as the suitable membranes for the VOC platform.  As OOC models are trying 
to replace animal derived membranes, materials like PCL can be used. With further 
functionalisation by adding RGD’s to the surface, peptide motifs would improve cell 
adhesion by attaching to the ECM, making this a potential membrane for not only for 
the VOC platform but for other OOC model too. 
5.5.2 Cell morphology observations on membranes 
To observe cell attachment on the electrospun membranes cells were cultured for a 
week and prepared for fluorescent and SEM imaging separately.  To prepare samples 
for fluorescent microscopy, the media was removed from the cell cultured membranes 
and washed in 1x PBS. This was then followed by a fixation process of 1:1 ratio of 
Acetone: Methanol and left to incubate for 20mins at -20°C. This step was done to 
ensure cells were fixed to the surface of the membrane for further analysis.  After 
incubation, the samples were then washed again with 1xPBS for 5 mins, the membranes 
were then gently moved onto a microscopic glass slide.  3-4 drops of Vectashield 
mounting medium with DAPI (Abcam, US) was added directly on the samples. DAPI was 
used to stain the nucleus of cells on the membranes and covered with a glass coverslip 
to be observed under the fluorescent microscope (Leica DM1400, Germany). 
5.5.3 Fluorescent staining o VK2/E6E7 cells on membranes 
Fluorescent staining with DAPI was performed on the PCL/GE, PCL/COL coaxial 
membranes and composite (PCL/GE) membrane to visualise the fixated cells attached 
to the nanofibers of the membranes. These three membranes were selected for further 
analyses as the MTT results identified these membranes as potential scaffolds for the 
VOC model. The samples were captured using the Leica DM1400 fluorescent 
microscope at magnification x10 Figure 5.8 shows the distribution of VK2/E6E7 vaginal 
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cells attached on the membranes (A) PCL/GE; (B) PCL/COL and (C) composite (PCL/GE). 
DAPI staining showed the fixated cells on the nanofibers and provided a visualisation of 
how well the membrane preformed after a week of experimenting with respect to cell 
adhesion, spread and proliferation.  
Figure 5.8 Fluorescent microscopy images of DAPI staining of VK2/E6E7 cells on (A) PCL/GE; (B) PCL/COL 
and (C) composite (PCL/GE) membrane at x10 magnification. 
Cell density of 25x10³ were seeded onto the circular membranes with a diameter of 
1.5cm. The electrospun membranes are made of multiple layers of randomised fibres 
spun on top of each other forming a 3D scaffold, due to this, cells can attach at different 
depths and therefore can be difficult to visualise as they may not appear is the same 







As experiments ran for a week it was expected that cells would proliferate and form 
colonies but under observation, cells remained single. This may be due to cells attaching 
at different location points on the membrane. It was noted that during conventional cell 
culture of VK2/E6E7 cells, it should normally take 3 days to proliferate into small 
colonies and only after a week would become confluent.  Therefore, further 
experimentation is required to evaluate the growth of vaginal tissue over a longer 
duration to observe focal adhesion where cells have differentiated, migrated and 
proliferated forming tissue. For better cell observation, confocal microscopy to 
observer the membranes in 3D to examine if cells have infiltration within the 
membrane.  
5.5.4 SEM imaging of VK2/E6E7 cells on membranes  
SEM was conducted to visualise cell attachment to the membrane fibres. To prepare 
the membranes for SEM, media was removed, and membranes were again washed with 
1xPBS and underwent the same fixation process of 1:1 ratio of Acetone: Methanol and 
left to incubate for 20mins at -20°C. Fixative solution was removed, and samples went 
through a series of washes again with 1xPBS followed by series of washes in 70% ethanol 
for 1 hour. The scaffolds were left to dry and were placed under UV to sterilise for 
30mins. The membranes were sputter coated (OM-SC7640, UK) in gold for 2mins at 1.5 
kV. Samples were then examined under the desktop SEM (JCM-6000, Japan) at an 





































Figure 510 Scanning Electron Microscopy image of VK2/E6E7 cells on (A, B and C) PCL/COL coaxial 






Figures 5.9 and 5.10 presents the SEM images of the early development of VK2/E6E7 
cells on both PCL/GE and PCL/COL membranes at a high magnification of x2000.  Circled 
in yellow in Figure 5.9 is thought to be vaginal cells but looked more like debris on the 
surface of the membrane. PCL/GE samples were limited during this experiment 
resulting to unavailable data, for future analysis more samples should be prepared to 
avoid lack of data. As the fluorescent image in Figure 5.8 (A) showed many vaginal cells 
had adhered to the surface, it would be beneficial to repeat this experiment to capture 
cells on the membrane as evidence to prove that this membrane is biocompatible. 
 
Figure 5.10 presents vaginal cells attached to the surface of the PCL/COL membrane, 
highlighted in yellow. As seen in Figure 10 (C) the cells have begun to attach to the fibres 
resulting in focal adhesion, spreading across the fibres. Further experimentation is 
required to understand the performance of cells and the membrane fibres for at least 
2 weeks to a month. Figure 5.11 shows a potential 3D cell on the surface of the 
membrane. However, after analysing the image closely, it was suggested that it could 
be an artefact, as cells after a week should adhere to the surface of the membrane. 
Unfortunately, composite membranes were unavailable for SEM analysis due to 
damaged samples. As cells were present on the membrane in Figure 5.8 (C), it would be 
beneficial to repeat SEM on this membrane to reflect the performance of cell 












Fluorescent image of PCL/GE membrane seen in Figure 5.8 (A) showed several cells 
attached to the surface of the membrane, however under SEM this was a difficult to 
process to identify them due to cells location on the fibres. As the membranes are 
porous, cells migrate within the mesh. SEM was only able to capture the cells attached 
to the top surface of the membrane and not within. Both membranes respectively had 
smooth and bead free nanofibers.  
5.6 Summary  
Vaginal epithelium cells are approximately 12-14µm in diameter, therefore it is essential 
to find a suitable membrane that vaginal cells would require to form tissue at the centre 
of the VOC platform. SEM was conducted on the following members to examine the 
morphology of the fibre diameter of PCL/GE 575.65± 142.628 nm, PCL/COL 540.55 ± 
293.09, composite (PLC/GE) 257.25± 72.92 nm. With thin nanofibers closely distributed 
to each other on the membrane, this  provided more connection points between the 
fibres increasing the mechanical strength  to support cell culture (Ramalingam et al., 
2019). The fabricated scaffolds must be able to withstand the mechanical forces exerted 
by the cells, which results in actin-myosin binding to the cytoskeleton, influencing the 
cell shape  and cellular functions that determine differentiation, proliferation and cell 
migration (Nuge et al., 2013). In Figure 5.10, it is assumed that cells were attached to 
the fibres as they seem to merge into the fibres indicating possible passive cell 
attachment. Due to limited literature available on the morphology of 3D vaginal cells on 
electrospun membranes, cells observed in Figure 5.10 were compared to bone-marrow 
stromal cells grown on gelatin/PCL membranes reported by Zhang et al., 2005 to obtain 







Figure 5.12  Interaction of bone-marrow stromal cells with gelatin/PCL composite fibrous scaffolds after 




To ensure the membranes selected for the VOC were capable of growing cells for 
longer than a week, further experiments must be conducted. As SEM images only 
provided a topological view of the cells attached to the fibres, Transmission electron 
microscopy (TEM) would be a suitable method to capture the internal structure of the 











The aim of this research was to develop a microfluidic device that could mimic the in-
vivo vaginal tissue, within an in-vitro system to gain a better understanding of BV. This 
was done by conducting individual experiments in design and mould fabrication, 
scaffold fabrication and cell culture. In chapter 3, the VOC platform designs were 
constructed and evaluated through 7 iterations. Moulds were created using material 
jetting for rapid prototyping and to provide a smooth surface finish for the easy removal 
of PDMS layers. PDMS material was selected as the favourable material to fabricate the 
VOC layers due to its versatile properties i.e., flexibility, processibility, and transparency. 
Transparency of PDMS offered the ability to visually see what was happening within the 
chip during experimentation e.g., flow experiments and fluorescent microscopy without 
having to disrupt the layers of the chip.  
As PDMS is permeable it allows for gas exchange to take place which is essential during 
cell culture. Though PDMS has its limitations especially being hydrophobic which results 
in non-specific absorption of protein at the surface, PDMS still remains the favourable 
material for fabricating OOC devices.  This is due it being cost effective, easily utilised, 
processed and modified for wide applications especially in biomedical research 
(Gökaltun et al., 2019).  
From the designs conducted in chapter 3 the final designed contained alignment posts 
to help with assembling the layers of the VOC platform. The alignment posts were 
inspired by Lego microfluidics (Vittayarukskul and Lee, 2017). Using these posts 
positioned at the corners of the moulds, this allowed the designs of each VOC layers to 
link and align perfectly. The alignment is crucial when integrating the platform as many 
aspects are involved. Design 2 in chapter 3, Table 3.1 contained small membrane 
holders on either side of the membrane area but due to the small size was not able to 
hold the static membrane in place. During the flow experiments, flow that passed over 
the membrane caused the membrane to sag exposing the corresponding channels 
which resulted in cross flow. The design was then revaluated a gasket layer was 
introduced in the final design to support the membrane suspension forming the central 
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layer of the VOC platform. The gasket layer is then positioned in line with the 
microfluidic channels that run above and below the membrane and sealing any exposed 
channels to prevent leakage.  
In chapter 4 PCL, PCL/GE, PCL/COL and composite membranes were fabricated to find 
the suitable scaffold to support vaginal tissue for the VOC platform. SEM was conducted 
on the membranes to identify the fibre morphology. From the SEM results PCL 
membrane had an average fibre diameter of 761.67 ±237.296 nm, PCL/GEL membrane 
575.65 ±142.628 nm, PCL/COL membrane 540.55 ±293.09 nm and Composite 
membrane 257.25± 72.919 nm. PCL, PCL/GE and composite membrane presented 
uniformed, bead free fibres. However, PCL/COL, though presented bead-free and 
smooth fibres, did not exhibit uniformity and contained large pores seen in chapter 4 
Figure 4.6.1 (E). It is difficult to successfully electrospin collagen as its structure is 
unstable causing it to denature therefore, collagen is usually spun with the combination 
of a synthetic polymers to enhance its mechanical properties and  fibre stability (Zheng 
et al., 2014). 
The composite membrane produced ultrathin fibres compared to PCL, PCL/GE and 
PCL/COL. PCL 8% and GEL 4% were combined to make a homogenous solution thus 
creating non-beaded, continuous and thin fibre distribution with an average fibre size 
of 250.34 ±79.257nm. This was in line with the literature, Ramalingam et al., 2019 
reported that  composite membranes have an average fibres diameter of 243±52nm. 
Whereas He et al. , 2014 reported composite membrane to have an average fibre size 
of 386.9±102.5 nm indicating that blended solutions produce ultrathin fibres in 
comparison to single or coaxal spinning. Composite membrane also expressed similar 
mechanical properties to non-prolapsed vaginal tissues (Baah-Dwomoh et al., 2016) 
with a strain value of 12% and stress rupture at 1.6 MPa compared to PCL, PCL/GE and 
PCL/COL membrane (Figure 4.7). However, the blending of the PCL and gelatin did not 
enhance the strength of fibres but produced thin fibrous mesh. This is probably due to 
immiscibility and microphase separation which causes slippage of chains under loading 
caused by weak physical interactions amongst the chains in composite solutions (Zhang 
et al., 2005).  
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Most OOC devices have used PDMS as the scaffold to support cell culture because of 
the many advantages the material provides i.e., biocompatible, flexible, transparent 
and permeable which are all ideal for cell culture. However, PDMS is hydrophobic and 
therefore is usually coated to modify the surface to hydrophilic. With this in mind, 
electrospinning technique was used to fabricate membranes as an alternative solution 
for the VOC device.  Contact angle measurements were carried out on the membranes 
to evaluate their wettability properties for the purpose of sample loading during cell 
culture and flow experiments. PCL, known to be hydrophobic had a contact angle of 
121.54° which expressed incomplete wettability. However, when PCL is combined with 
biopolymers GE and COL the contact angle is reduced resulting with a more hydrophilic 
surface. PCL/GE and PCL/COL as well as composite membranes presented contact 
angles of below <90° indicating good wetting.  
Furthermore, biocompatibility experiments were conducted to identify a suitable 
membrane for the VOC platform. MTT assay was performed to test for cell viability. 
After conducting a two-sample t-test with equal variance results indicated that there 
was a significant difference between the cell viability and the control at 95% confidence 
for the composite membrane with a p-value <0.05. After week in culture the composite 
membrane expressed 140% in cell viability compared to the control at 100% clearly 
emphasizing it to be the most suitable membrane of choice for the VOC platform.  
However, in contrast the PCL membrane showed a significant difference in cell viability 
between the control and PCL membrane with a p-value < 0.05. After a week the cell 
viability on the PCL remained at 40% compared to PCL/GE at 100% and PCL/COL at 65% 
in relation to the control sample, signifying that PCL was not a suitable membrane for 
the VOC platform (Figure 5.7).  PCL/GE and PCL/COL presented good cell viability but 
composite membrane remined to the most appropriate membrane at 24 hrs, 72 hrs and 
168 hrs. The two-sample t-test was also used to compare any differences between the 
membranes. It was noted that the composite membrane revealed a significant 
difference with PCL, PCL/GE, PCL/COL membrane during the 72 hrs (Figure 5.6). At 168 
hrs, composite membrane proved to be the most suitable membrane with a cell viability 
of 140% compared to the control suggesting good viability in comparison to PCL/GE and 
PCL/COL seen in chapter 5 Figure 5.7.   
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MTT assay was done to confirm cell viability but to ensure cells had attached to the 
membrane fluorescent imaging. DAPI was used to stain the nucleus of the viable cells 
to visualise cell attachment. PCL/GE, PCL/COL and composite membranes were 
available for analysis. In chapter 5 Figure 5.8. demonstrated fluorescent microscopy 
images of DAPI staining on VK2/E6E7 cells attached to (A) PCL/GE, (B) PCL/COL and (C) 
composite (PCL/GE) membrane at x10 magnification. The images indicated cells had 
attached to the membranes but remained as single cells after a week in culture. As 
membranes are 3D scaffolds, cells attach to the fibres in different locations making it 
difficult to see whether cells have proliferated on the fibres or whether they have 
infiltrated the membrane.  SEM analysis was also conducted to visualise the interaction 
of cells with the scaffold which can be seen in chapter 5 Figure 5.10. From observation 
it was noted that cells started to merge with the fibres. However, SEM is unable to 
capture cells embedded within the fibres. Therefore, it is recommended to conduct 
confocal microscopy to examine the migration and infiltration of cells within in the 
membrane.  
 
Tensile strength measurements were conducted on the membrane which indicated 
similar stress and strain values in comparison to vaginal tissue from non-prolapsed 
women. Baah-Dwomoh et al 2016 reported that non-prolapsed tissue indicated a strain 
at failure ranging from 20-46% and stress at failure ranging from 0.82-2.62MPa. The 
composite membrane demonstrated similar properties with strain at failure 12 % and 
stress at rupture 1.6 MPa (Figure 4.8) suggesting that it would be a suitable membrane 
to support vaginal tissue. Whereas PCL membrane had a strain at failure 65% and stress 
at rupture 1.4 MPa, PCL/GE membrane strain at failure 8% and stress at rupture 1.7 
MPa (Figure 4.7), PCL/COL membrane strain at failure 43% and stress at rupture 1.2 
MPa and composite membrane strain at failure 12 % and stress at rupture 1.6 MPa 
(Figure 4.7). The young’s modulus expressed the stiffness of each membrane evaluated 
PCL 25.8kPa, PCL/GE 0.60MPa, PCL/COL 35.5kPa and composite 0.42MPa. PCL/COL and 
PCL (Figure 4.7) expressed viscoelastic properties whereas PCL/GE and composite 
membrane demonstrated elastic properties with respect to vaginal tissue. It was 
indicated that vaginal tissue has an elastic modulus in the range of 2.5-9.5MPa but was 
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suggested by Baah-Dwomoh et al 2016 that vaginal tissue is nonlinear elastic and 
undergoes large deformations. 
With design implementation and chip fabrication conducted in chapter 3, the final 
design for the VOC platform was selected. This was then followed by the fabrication of 
four electrospun membranes in Chapter 4. The membranes were designed to mimic the 
ECM to support vaginal tissue, once implemented into the VOC model. In chapter 5 
biocompatibility experiments were conducted on the membranes to identify the most 
appropriate scaffold for the VOC platform. Each element of the VOC platform was 
carried out individually, the final step of this research was to combine all the individual 
components together to form a working VOC prototype.   
6.1 VOC Integration  
The initial flow experiment for the VOC platform was to provide nutrients to the 
epithelial cells grown at the centre of the chip. The VOC contains two microfluidic 
channels, top and bottom channel to provide nutrients to the vaginal epithelial. The 
platform is currently at this stage in testing. Once the working prototype has 
successfully formed vaginal epithelial tissue the platform will then introduce the second 
cell type, the endothelial cells to form the blood capillaries (Figure 6.1).  As seen in 
Figure 6.1 the VOC platform has been designed with two microfluidic channels for the 
purpose of future experiments to combining two cell types.  
 
    Figure 6.1 presents the potential layers of the VOC platform (created in BioRender.com) 
The VOC platform contains a membrane that has been fabricated using bio and 
synthetic polymers via electrospinning to mimic the ECM for the prospects of 3D cell 
culture. OOC devices previously manufacture utilises PDMS as their porous membrane 
due to its advantageous properties of being flexible, semi permeable, transparent and 
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biocompatible, however it has its limitations. PDMS is known to absorb small 
hydrophobic molecule which can compromise measuring drug efficacy and toxicity (Huh 
et al., 2013). Therefore, the electrospun membrane is used as the scaffold for the VOC 
platform to support the growth of vaginal tissue.  The membrane is made with 
biodegradable material that has biocompatible and mechanical properties to aid the 
formation of 3D cells. Biodegradable material was chosen for the VOC platform as cells 
would eventually release chemical cues which would slowly degrade the nanofibers of 
the membrane leaving only vaginal tissue at the centre of the VOC platform. The 
platform has the potential to be used as a research tool to understand conditions like 
BV and other pathogen that affect the vaginal ecosystem. The VOC can be used by 
researcher and clinicians to develop improved treatment and eventually personalised 
medicine.  
Another method was also investigated as an alternative approach to fabricating the VOC 
platform. 3D printing is an alternative method to creating a rapid prototype, Figure 6.2 
(A) presents the first 3D printed VOC model in VeroClear (Stratasya, US). The layers of 
the chip were printed on the Objet30 Pro (Stratasys, US).  The final designed from 
chapter 3 Figure 3.9. Includes the alignment posts that aids to connect each layer into 
one device. However, with 3D printed layers treatment is required to bond layers, 
preventing the chip from leaking. Unlike the PDMS VOC models, tubing must be 
connected to the chip using Luer locks to run flow experiments. This method has the 
potential for manufacturing multiple chips rapidly for larger experiments, but materials 











Seen in Figure 6.2 (B) another design was implemented for 3D printing layers of the VOC 
platform using TPU. The design was based around the Lego concept, but the layers were 
confined into a single unit containing the top and bottom channel layers as an 
enclosure. This idea was to create a chip containing a completely sealed chip with 
interlocking layers. With the interlocking feature the design potentially replace the need 
for bonding treatment and can prevent leakage. TPU is a thermoplastic polymer that is 
high in durability and flexibility and has similar characteristics to rubber, commonly used 
to for fabricating wires, breathable films and textile coatings. With great versatility, it 
provides another alternative approach to fabricating OOC device. However, TPU is 
opaque making it difficult to visualise cells for microscopy image analyses and difficult 
to bond to surfaces but, has the potential to replace PDMS as the main material used 
















Chapter 7 – Conclusion  
 
The aim of this research was to create a 3D microfluidic device that would have the 
ability to mimic in-vivo vaginal tissue, within an in-vitro system. The VOC platform was 
based on the OOC concept, a novel approach combining biology and engineering to 
mimic the biochemical, mechanical and physical aspects of vaginal tissue. To create this 
microfluidic device a combination of techniques was used to construct the individual 
components of the chip. The process was split into three different areas, design and 
chip manufacturing, membrane fabrication and cell culture.  
In chapter 3 design and fabrication, an engineering design process was conducted to 
identify the optimal design. The seventh design containing alignment posts and a gasket 
later was fabricated using soft lithography method. The layers of the VOC were 
manufacture using PDMS, a flexible transparent elastomer ideal for rapid prototype. 
The alignment posts were a vital addition to the design to improve alignment of the 
three main layers that make up the VOC platform. Initial flow testing was conducted on 
the VOC prototype using a syringe pump, which presented preliminary results on the 
performance of the VOC design. However, further testing is required to fully evaluate 
the VOC platform as a whole unit including the electrospun membrane and cells to 
obtain a fully developed model.  
One of the objectives mentioned in chapter 1.2 was to create a biocompatible 
membrane. In chapter 4, membranes were fabricated using the electrospinning 
technique. This method was chosen as an alternative method to PDMS to create a 
biodegradable and biocompatible membrane that would mimic the ECM to support 
vaginal epithelial cells at the centre of the VOC platform. Biopolymers GE and COL were 
both selected due to their biodegradability, biocompatibility and fluid retention 
properties but lack mechanical strength. To improve their mechanical strength 
synthetic polymer PCL was used in combination with the biopolymers to fabricate 
membranes via co-axial and composite electrospinning. Membranes PCL/GE, PCL/COL 
and composite provided good mechanical strength and biocompatibility characteristics 
to support the growth of vaginal tissue. Fibre diameter measurements, mechanical 
testing and contact angle were conducted on all four membranes to help identified the 
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appropriate membrane for the VOC platform. To conclude PCL/GE and composite 
membranes indicated the most suitable for the platform. 
In Chapter 5 the membranes were analysed for their biocompatibility with vaginal cell 
line VK2/E6E7. Cell viability tests were conducted on the membranes and concluded 
that the composite membrane was the most suitable membrane for the VOC platform. 
This was highlighted in the statistical analysis conducted on the membranes. The 
composite membrane had a significant difference in relation to the control but also with 
the other membranes. More cells were viable on the composite membrane than on the 
PCL/GE and PCL/COL membrane. From the statistical analysis it was concluded that PCL 
membrane would not be suitable for the VOC platform and would require further 
treatment to enhance the surface properties to become more biocompatible. 
Fluorescent imagining conducted on the PCL/GE, PCL/COL and composite membranes 
demonstrated cells were adherent to the surface of the membrane and distributed 
evenly across the membrane. SEM done on the PCL/GE and PCL/COL membrane 
showed the cells merging with the fibres indicating integrin bonding, cell attached after 
a week in culture. To conclude PCL/GE, PCL/COL and composite membrane expressed 
biocompatibility but overall, the composite membrane is the most fitting membrane for 
the VOC platform.   
The final step in this research project was to amalgamate each component of the VOC 
system into one integrated platform and to validate the platform by conducting fluidic 
experiments. However, due to the unforeseen circumstances of the pandemic the final 
flow experiments were not achieved. Therefore, to conclude further experimentation 
is required to validate the performance of the VOC platform before challenging the 
system with bacterial strains to investigate what causes BV.  
7.1 Contribution to knowledge 
The research conducted in this thesis has contributed knowledge to the following 
areas: -  
• OOC Design  
The VOC has been designed to contain 3 layers with the central layer acting as a gasket 
to hold the membrane in suspension. The gasket layer has also been designed to cover 
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exposing channels to prevent leakage. Unlike other OOC devices that require additional 
casing to hold the chip together, the VOC platform design includes additional feature 
i.e., alignment posts based at the corners of the chip for easy assembling similar to Lego. 
This provides a plug and connect system which helps with alignment of the layers and 
supports the membrane.  
 
• New membrane on which vaginal cells have been successfully seeded  
Vaginal cells have only been grown using conventional 2D methods and 3D models 
including the RWV but an electrospun membrane has been developed using a mixture 
of bio and synthetic polymers to support the growth of vaginal epithelial cells.  
 
• VOC platform an alternative solution to replacing animal testing 
A novel approach to understanding BV, the VOC platform is a working prototype in its 
initial stages of development designed to mimic the function of the human vagina, 
physiology and model its natural microbiome environment. The VOC is a realistic 
platform designed to examine the interaction between vaginal epithelial cells, bacterial 
strains and pathogens that affect the vaginal environment. Development of new drugs 
and treatment for BV can be directly tested on this platform and has the potential to 





Chapter 8 – Future Work   
 
The VOC platform has the potential to replace animal testing and provide a model 
researchers and clinicians could use to understand BV. However, the platform requires 
further validation as an integrated system therefore the following suggestions have 
been recommended as future work: - 
• Flow experiments with the Elveflow system to test the integrated platform 
and its performance.   
To test the VOC platform as a fully integrated system using the ELVEFLOW microfluidic 
flow controller and sensor to control cell culture experiment on the VOC platform for at 
least a week to validate the platform performance.  














Figure 8.1 Integrated VOC platform under flow experiment through with the Elveflow system. 
To conduct the experiment, the VOC platform would be prepared in advance, sterilised 
under UV for 20mins before the experiment and stored ready for use. The VOC must be 
contaminated free during the experiments. To run the experiment a flask of vaginal cells 
must be grown separately prior to the set up in order seed the VOC with single cell 
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suspension of approximately 25,000 cells/ml. This step is done under the flow cabinet 
before attaching to the flow system. The cells should then be carefully passed through 
the inlet till the membrane and channels are completed full of media and cells 
suspension. The VOC platform should then be left for 24 hours in the incubator at 37°C 
with 5% CO2. This is so the cells can attach to the surface of the membrane. The 
composite membrane is used at the centre of the chip to support the growth of vaginal 
epithelial cells. 
After 24 hours incubation period, media is slowly pumped out and replaced with fresh 
media. The VOC is then connected to the Elveflow OB1 Mk3 pressure controlling system 
seen in Figure 8.1. The inlet of the chip in connected to a reservoir with KSF media to 
provide nutrients to the vaginal cells growing at the centre of the chip. Between the 
reservoir and the chip, a flow sensor is located which is set as a PID feedback loop in 
order to monitor the flow rate and pressure exerted by the OB1 Mk3 system. The outlet 
of the chip is connected to a 50 ml centrifuge tube to collect waste. To initiate the flow, 
the OB1 Mk3 pressure controlling system is supplied with 5% CO2. The pressure limits 
are set to a minimum and maximum of 80 mbar, with a pressure set to 15 mbar to run 
the experiment. During the experiment, the flow sensor monitors the flow rate during 
the experiment.  
Once the VOC platform is connected to the system and media is flowing through the 
channels, the chip is then placed into the incubator at 37°C with 5% CO2 to conduct the 
cell culture experiment. The OB1 Mk3 pressure controller has the ability to conduct 
multiple chips in one set up, ideal for larger data collection and analysis. As the 
membrane is opaque once the tissue has formed on the membrane it can then be used 
for further biological and fluorescent imaging analysis. With the Elveflow set up the VOC 
platform can be evaluated by observing the design performance by checking for leakage 
or blockage during the experiments, whether the layers have completed bonded and 






• Successfully try to grow 3D vaginal tissue on the VOC platform. 
To ensure the membrane can support the growth of 3D vaginal tissue, the VOC platform 
can be used to run 2 weeks to a month-long experiment to examine the membranes 
and their ability to form 3D cells.  SEM and TEM can then be conducted to study the 
morphology of the vaginal tissue from the VOC platform.  
• To check infiltration by conducting confocal microscopy image analysis. 
 
To examine cells migration within the fibers of the membrane, confocal imaging would 
be beneficial. Fiber diameter of the membrane can affect the migration of cells, 
therefore confocal imaging would provide an insight to whether the appropriate 
membrane has been selected for the VOC platform.  
 
• Seed bacterial strains to the top layer of the VOC to establish the vaginal 
microbiome environment. 
Once the VOC platform has formed vaginal tissues, Lactobacillus spp. can then be 
introduced to the system to mimic the microbiome of the vagina. The model can then 
be used to investigate the interaction between vaginal epithelial cells and bacterial 
strains like BV and other pathogen. This can then be monitored over a period of time to 
investigate whether GV biofilm emerges. To test the formation of the biofilm, pH 
bacterial proliferation and viability assay will be conducted. To verify bacterial adhesion 
to the epithelial cells TEM will be performed on dissected cross section of the VOC 
tissue. 
• To measure porosity and degradation tests on membranes. 
To measure porosity of the membranes to ensure the appropriate membrane is used 
for the VOC platform. Degradation tests must also be considered to evaluate how long 
it would take the membrane to degrade. Over time as the cells grow and attached the 
membrane the material should degrade leaving behind 3D vaginal tissue. To test 
degradation rate, membrane samples will be exposed in media and monitored over a 
time frame. At each data point SEM images of the samples will be taken to capture the 
degradation of the membrane. Membranes will also be exposed to media with 
bacteria, monitored and compared to membranes only with media to examine if there 
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